| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.983 | 0 | 0.983 | Adenosine deaminase inhibitor | 0.966 0 DBMET00485 0.909 0.001 DBMET00496 0.966 0 DBMET03265 0.11 0.004 DBMET00493 0.981 0 DB00171 0.085 0.008 DBMET00499 0.061 0.02 DBMET00498 | ||
| 0.952 | 0.002 | 0.986 | Vasodilator, coronary | 0.862 0.003 DBMET00485 0.555 0.01 DBMET00496 0.862 0.003 DBMET03265 0.232 0.153 DBMET00493 0.986 0.002 DB00171 0.235 0.149 DBMET00499 | DB00171 | |
| 0.93 | 0.001 | 0.93 | Adenosine A1 receptor antagonist | 0.712 0.002 DBMET00485 0.814 0.002 DBMET00496 0.712 0.002 DBMET03265 0.287 0.007 DBMET00493 0.446 0.004 DB00171 0.354 0.005 DBMET00499 0.112 0.021 DBMET00498 | ||
| 0.929 | 0 | 0.995 | Adenosine kinase inhibitor | 0.975 0 DBMET00485 0.331 0.001 DBMET00496 0.975 0 DBMET03265 0.995 0 DB00171 | DB00171 | |
| 0.9 | 0.001 | 0.9 | Adenosine A2a receptor antagonist | 0.528 0.003 DBMET00485 0.643 0.002 DBMET00496 0.528 0.003 DBMET03265 0.193 0.01 DBMET00493 0.372 0.004 DB00171 0.248 0.007 DBMET00499 0.065 0.04 DBMET00498 | ||
| 0.897 | 0 | 0.962 | NADH dehydrogenase inhibitor | 0.952 0 DBMET00485 0.799 0.001 DBMET00496 0.952 0 DBMET03265 0.411 0.004 DBMET00493 0.962 0 DB00171 0.456 0.004 DBMET00499 0.223 0.009 DBMET00498 0.118 0.03 DB11100 | DB00171 | |
| 0.895 | 0.002 | 0.985 | DNA synthesis inhibitor | 0.958 0.001 DBMET00485 0.878 0.002 DBMET00496 0.958 0.001 DBMET03265 0.412 0.02 DBMET00493 0.985 0.001 DB00171 0.416 0.02 DBMET00499 0.279 0.051 DBMET00498 0.25 0.066 DB11100 | DB00171 | |
| 0.892 | 0.001 | 0.892 | Adenosine A2 receptor antagonist | 0.519 0.003 DBMET00485 0.698 0.002 DBMET00496 0.519 0.003 DBMET03265 0.236 0.008 DBMET00493 0.333 0.005 DB00171 0.319 0.005 DBMET00499 0.068 0.041 DBMET00498 | ||
| 0.887 | 0.003 | 0.945 | Vasodilator, peripheral | 0.843 0.003 DBMET00485 0.644 0.011 DBMET00496 0.843 0.003 DBMET03265 0.945 0.002 DB00171 | DB00171 | |
| 0.87 | 0 | 0.974 | Phosphofructokinase-1 inhibitor | 0.954 0 DBMET00485 0.55 0.002 DBMET00496 0.954 0 DBMET03265 0.108 0.029 DBMET00493 0.974 0 DB00171 0.142 0.02 DBMET00499 0.083 0.039 DBMET00498 0.074 0.045 DB11100 | DB00171 | |
| 0.852 | 0.001 | 0.974 | Glutamate dehydrogenase inhibitor | 0.948 0 DBMET00485 0.596 0.002 DBMET00496 0.948 0 DBMET03265 0.131 0.019 DBMET00493 0.974 0 DB00171 0.139 0.018 DBMET00499 0.081 0.043 DBMET00498 0.097 0.032 DB11100 | DB00171 | |
| 0.843 | 0.001 | 0.975 | Fumarate hydratase inhibitor | 0.958 0 DBMET00485 0.41 0.002 DBMET00496 0.958 0 DBMET03265 0.041 0.018 DBMET00493 0.975 0 DB00171 0.058 0.011 DBMET00499 0.033 0.026 DB11100 | DB00171 | |
| 0.84 | 0 | 0.974 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.956 0 DBMET00485 0.632 0.002 DBMET00496 0.956 0 DBMET03265 0.199 0.073 DBMET00493 0.974 0 DB00171 0.222 0.057 DBMET00499 0.244 0.045 DBMET00498 | DB00171 | |
| 0.832 | 0.001 | 0.986 | RNA-directed DNA polymerase inhibitor | 0.954 0.001 DBMET00485 0.751 0.002 DBMET00496 0.954 0.001 DBMET03265 0.421 0.016 DBMET00493 0.986 0 DB00171 0.473 0.012 DBMET00499 0.337 0.026 DBMET00498 0.331 0.026 DB11100 | DB00171 | |
| 0.822 | 0.002 | 0.822 | Cyclic AMP phosphodiesterase inhibitor | 0.691 0.003 DBMET00485 0.726 0.003 DBMET00496 0.691 0.003 DBMET03265 0.49 0.007 DBMET00493 0.504 0.006 DB00171 0.734 0.003 DBMET00499 0.291 0.045 DBMET00498 | ||
| 0.818 | 0 | 0.954 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.925 0 DBMET00485 0.532 0.001 DBMET00496 0.925 0 DBMET03265 0.114 0.012 DBMET00493 0.954 0 DB00171 0.182 0.007 DBMET00499 0.136 0.009 DBMET00498 0.064 0.031 DB11100 | DB00171 | |
| 0.806 | 0.001 | 0.806 | Adenosine A1 receptor agonist | 0.652 0.002 DBMET00485 0.356 0.002 DBMET00496 0.652 0.002 DBMET03265 0.474 0.002 DB00171 | ||
| 0.791 | 0.002 | 0.791 | DNA methylase inhibitor | 0.789 0.002 DBMET00485 0.528 0.005 DBMET00496 0.789 0.002 DBMET03265 0.731 0.002 DB00171 | ||
| 0.778 | 0.001 | 0.968 | Argininosuccinate synthase inhibitor | 0.944 0 DBMET00485 0.453 0.002 DBMET00496 0.944 0 DBMET03265 0.129 0.014 DBMET00493 0.968 0 DB00171 0.2 0.008 DBMET00499 0.064 0.034 DBMET00498 0.077 0.026 DB11100 | DB00171 | |
| 0.772 | 0 | 0.937 | Carbamoyl phosphate synthetase inhibitor | 0.895 0 DBMET00485 0.621 0.001 DBMET00496 0.895 0 DBMET03265 0.174 0.009 DBMET00493 0.937 0 DB00171 0.199 0.007 DBMET00499 0.109 0.018 DBMET00498 0.132 0.014 DB11100 | DB00171 | |
| 0.776 | 0.005 | 0.776 | Immunomodulator | 0.755 0.005 DBMET00485 0.581 0.013 DBMET00496 0.755 0.005 DBMET03265 0.219 0.142 DBMET00493 0.75 0.005 DB00171 0.192 0.174 DBMET00499 0.439 0.034 DBMET00498 | ||
| 0.76 | 0.001 | 0.76 | Adenosine A3 receptor antagonist | 0.493 0.003 DBMET00485 0.658 0.002 DBMET00496 0.493 0.003 DBMET03265 0.279 0.006 DBMET00493 0.479 0.003 DB00171 0.348 0.004 DBMET00499 0.148 0.013 DBMET00498 | ||
| 0.748 | 0.001 | 0.972 | Ornithine carbamoyltransferase inhibitor | 0.937 0 DBMET00485 0.342 0.004 DBMET00496 0.937 0 DBMET03265 0.073 0.024 DBMET00493 0.972 0 DB00171 0.1 0.016 DBMET00499 0.047 0.043 DBMET00498 0.073 0.024 DB11100 | DB00171 | |
| 0.739 | 0.002 | 0.965 | Aldehyde dehydrogenase inhibitor | 0.94 0.001 DBMET00485 0.394 0.005 DBMET00496 0.94 0.001 DBMET03265 0.134 0.058 DBMET00493 0.965 0.001 DB00171 | DB00171 | |
| 0.732 | 0.001 | 0.866 | Adenylate cyclase inhibitor | 0.811 0.001 DBMET00485 0.61 0.004 DBMET00496 0.811 0.001 DBMET03265 0.175 0.032 DBMET00493 0.866 0 DB00171 0.346 0.01 DBMET00499 | DB00171 | |
| 0.72 | 0.002 | 0.72 | DNA methyltransferase I inhibitor | 0.322 0.019 DBMET00485 0.391 0.01 DBMET00496 0.322 0.019 DBMET03265 0.174 0.084 DB00171 | ||
| 0.695 | 0 | 0.695 | Adenosine A2 receptor agonist | 0.248 0.001 DBMET00485 0.192 0.001 DBMET00496 0.248 0.001 DBMET03265 0.015 0.013 DBMET00493 0.183 0.001 DB00171 | ||
| 0.656 | 0.002 | 0.97 | Heat shock protein 70 antagonist | 0.868 0.001 DBMET00485 0.191 0.008 DBMET00496 0.868 0.001 DBMET03265 0.13 0.119 DBMET00493 0.97 0 DB00171 | DB00171 | |
| 0.655 | 0.001 | 0.655 | Adenosine A2b receptor agonist | 0.285 0.002 DBMET00485 0.13 0.002 DBMET00496 0.285 0.002 DBMET03265 0.155 0.002 DB00171 | ||
| 0.647 | 0 | 0.825 | Biliverdin reductase inhibitor | 0.825 0 DBMET00485 0.452 0.002 DBMET00496 0.825 0 DBMET03265 0.155 0.009 DBMET00493 0.825 0 DB00171 0.232 0.004 DBMET00499 0.129 0.012 DBMET00498 0.112 0.015 DB11100 | DB00171 | |
| 0.638 | 0.001 | 0.954 | Thymidine kinase inhibitor | 0.872 0.001 DBMET00485 0.795 0.001 DBMET00496 0.872 0.001 DBMET03265 0.151 0.004 DBMET00493 0.954 0 DB00171 0.189 0.003 DBMET00499 0.098 0.006 DBMET00498 0.037 0.035 DB11100 | DB00171 | |
| 0.63 | 0 | 0.851 | Adenylate kinase inhibitor | 0.756 0 DBMET00485 0.457 0.002 DBMET00496 0.756 0 DBMET03265 0.195 0.016 DBMET00493 0.851 0 DB00171 0.163 0.022 DBMET00499 0.122 0.042 DBMET00498 0.144 0.029 DB11100 | DB00171 | |
| 0.637 | 0.014 | 0.637 | Cholesterol antagonist | 0.333 0.072 DBMET00485 0.326 0.075 DBMET00496 0.333 0.072 DBMET03265 0.188 0.175 DB00171 | ||
| 0.623 | 0 | 0.993 | Phosphoglycerate kinase inhibitor | 0.971 0 DBMET00485 0.422 0.002 DBMET00496 0.971 0 DBMET03265 0.032 0.029 DBMET00493 0.993 0 DB00171 0.033 0.027 DBMET00499 | DB00171 | |
| 0.608 | 0.001 | 0.736 | UDP-glucose 4-epimerase inhibitor | 0.693 0 DBMET00485 0.532 0.002 DBMET00496 0.693 0 DBMET03265 0.149 0.029 DBMET00493 0.736 0 DB00171 0.196 0.019 DBMET00499 0.116 0.046 DBMET00498 0.143 0.031 DB11100 | DB00171 | |
| 0.613 | 0.015 | 0.695 | Immunostimulant | 0.695 0.008 DBMET00485 0.593 0.017 DBMET00496 0.695 0.008 DBMET03265 0.179 0.134 DBMET00493 0.679 0.009 DB00171 0.159 0.147 DBMET00499 0.32 0.073 DBMET00498 | DBMET03265 | |
| 0.579 | 0.002 | 0.899 | Antimetabolite | 0.834 0.001 DBMET00485 0.505 0.002 DBMET00496 0.834 0.001 DBMET03265 0.146 0.012 DBMET00493 0.899 0.001 DB00171 0.191 0.01 DBMET00499 0.168 0.011 DBMET00498 0.05 0.031 DB11100 | DB00171 | |
| 0.55 | 0.005 | 0.79 | Cytidine deaminase inhibitor | 0.666 0.004 DBMET00485 0.615 0.004 DBMET00496 0.666 0.004 DBMET03265 0.79 0.002 DB00171 0.155 0.072 DBMET00499 0.194 0.05 DBMET00498 | DB00171 | |
| 0.54 | 0.007 | 0.54 | Interleukin agonist | 0.448 0.013 DBMET00485 0.497 0.009 DBMET00496 0.448 0.013 DBMET03265 0.173 0.146 DBMET00493 0.321 0.039 DB00171 | ||
| 0.534 | 0.002 | 0.698 | DNA repair enzyme inhibitor | 0.698 0.002 DBMET00485 0.552 0.002 DBMET00496 0.698 0.002 DBMET03265 0.168 0.019 DBMET00493 0.41 0.003 DB00171 0.237 0.006 DBMET00499 0.199 0.009 DBMET00498 | DBMET03265 | |
| 0.525 | 0.003 | 0.878 | Hexokinase inhibitor | 0.756 0.001 DBMET00485 0.435 0.004 DBMET00496 0.756 0.001 DBMET03265 0.878 0.001 DB00171 0.123 0.114 DBMET00499 | DB00171 | |
| 0.501 | 0.004 | 0.736 | DNA polymerase I inhibitor | 0.602 0.003 DBMET00485 0.532 0.004 DBMET00496 0.602 0.003 DBMET03265 0.514 0.004 DBMET00493 0.736 0.001 DB00171 0.444 0.005 DBMET00499 0.17 0.039 DBMET00498 | DB00171 | |
| 0.503 | 0.012 | 0.572 | Vasodilator | 0.5 0.012 DBMET00485 0.372 0.028 DBMET00496 0.5 0.012 DBMET03265 0.283 0.054 DBMET00493 0.543 0.009 DB00171 0.572 0.007 DBMET00499 | DBMET00499 | |
| 0.483 | 0.001 | 0.883 | Purinergic P2X1 antagonist | 0.79 0 DBMET00485 0.273 0.002 DBMET00496 0.79 0 DBMET03265 0.104 0.015 DBMET00493 0.883 0 DB00171 0.083 0.023 DBMET00499 0.143 0.008 DBMET00498 | DB00171 | |
| 0.484 | 0.003 | 0.702 | Aminoacyl-tRNA synthetase inhibitor | 0.589 0.003 DBMET00485 0.363 0.005 DBMET00496 0.589 0.003 DBMET03265 0.702 0.002 DB00171 | DB00171 | |
| 0.485 | 0.006 | 0.853 | Phospholipase C inhibitor | 0.853 0.002 DBMET00485 0.174 0.068 DBMET00496 0.853 0.002 DBMET03265 0.652 0.003 DB00171 | DBMET03265 | |
| 0.462 | 0 | 0.462 | Adenosine A2a receptor agonist | 0.209 0.001 DBMET00485 0.083 0.002 DBMET00496 0.209 0.001 DBMET03265 0.107 0.001 DB00171 | ||
| 0.477 | 0.017 | 0.477 | Hypoxia-inducible factor 1 alpha inhibitor | 0.23 0.119 DBMET00485 0.402 0.029 DBMET00496 0.23 0.119 DBMET03265 0.287 0.072 DBMET00493 0.188 0.167 DBMET00499 | ||
| 0.434 | 0.002 | 0.958 | Purinergic P2Y antagonist | 0.86 0.001 DBMET00485 0.115 0.008 DBMET00496 0.86 0.001 DBMET03265 0.958 0 DB00171 0.052 0.025 DBMET00499 0.088 0.011 DBMET00498 | DB00171 | |
| 0.472 | 0.041 | 0.566 | Immunosuppressant | 0.566 0.018 DBMET00485 0.496 0.034 DBMET00496 0.566 0.018 DBMET03265 0.202 0.195 DBMET00493 0.498 0.034 DB00171 | DBMET03265 | |
| 0.432 | 0.006 | 0.432 | Protein kinase stimulant | 0.412 0.007 DBMET00485 0.267 0.022 DBMET00496 0.412 0.007 DBMET03265 0.21 0.038 DB00171 | ||
| 0.424 | 0.001 | 0.424 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.253 0.002 DBMET00485 0.142 0.003 DBMET00496 0.253 0.002 DBMET03265 0.217 0.002 DB00171 | ||
| 0.423 | 0.002 | 0.423 | Adenosine A3 receptor agonist | 0.249 0.002 DBMET00485 0.252 0.002 DBMET00496 0.249 0.002 DBMET03265 0.18 0.003 DB00171 | ||
| 0.438 | 0.021 | 0.438 | DNA damaging | 0.342 0.043 DBMET00485 0.241 0.086 DBMET00496 0.342 0.043 DBMET03265 0.281 0.065 DB00171 | ||
| 0.412 | 0.003 | 0.412 | Adenosine A2b receptor antagonist | 0.131 0.007 DBMET00485 0.242 0.004 DBMET00496 0.131 0.007 DBMET03265 0.134 0.007 DBMET00493 0.046 0.038 DB00171 0.332 0.003 DBMET00499 0.045 0.04 DBMET00498 | ||
| 0.454 | 0.055 | 0.454 | Antibacterial | 0.426 0.066 DBMET00485 0.444 0.059 DBMET00496 0.426 0.066 DBMET03265 0.343 0.106 DB00171 | ||
| 0.397 | 0.004 | 0.591 | Alcohol dehydrogenase inhibitor | 0.589 0.002 DBMET00485 0.184 0.014 DBMET00496 0.589 0.002 DBMET03265 0.109 0.044 DBMET00493 0.591 0.002 DB00171 0.13 0.029 DBMET00499 | DB00171 | |
| 0.394 | 0.001 | 0.394 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.194 0.002 DBMET00485 0.111 0.008 DBMET00496 0.194 0.002 DBMET03265 0.094 0.018 DBMET00493 0.14 0.004 DB00171 0.078 0.04 DBMET00499 | ||
| 0.38 | 0 | 0.48 | Acyl-CoA dehydrogenase inhibitor | 0.461 0 DBMET00485 0.263 0.002 DBMET00496 0.461 0 DBMET03265 0.125 0.012 DBMET00493 0.48 0 DB00171 0.081 0.022 DBMET00499 0.049 0.043 DBMET00498 | DB00171 | |
| 0.415 | 0.046 | 0.581 | Antithrombotic | 0.581 0.018 DBMET00485 0.285 0.099 DBMET00496 0.581 0.018 DBMET03265 0.487 0.031 DB00171 | DBMET03265 | |
| 0.424 | 0.058 | 0.424 | Transcription factor NF kappa B inhibitor | 0.27 0.113 DBMET00485 0.315 0.087 DBMET00496 0.27 0.113 DBMET03265 | ||
| 0.363 | 0.022 | 0.363 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.159 0.133 DBMET00485 0.159 0.133 DBMET03265 0.177 0.111 DB11100 | ||
| 0.33 | 0.002 | 0.826 | Inosine monophosphate dehydrogenase inhibitor | 0.826 0.001 DBMET00485 0.132 0.004 DBMET00496 0.826 0.001 DBMET03265 0.816 0.001 DB00171 0.053 0.013 DBMET00498 | DBMET03265 | |
| 0.336 | 0.015 | 0.336 | Peptidyltransferase inhibitor | 0.275 0.035 DBMET00485 0.326 0.017 DBMET00496 0.275 0.035 DBMET03265 0.248 0.052 DB00171 0.26 0.044 DBMET00499 0.24 0.058 DB11100 | ||
| 0.34 | 0.022 | 0.34 | Platelet adhesion inhibitor | 0.324 0.026 DBMET00485 0.227 0.058 DBMET00496 0.324 0.026 DBMET03265 0.298 0.035 DB00171 | ||
| 0.311 | 0.001 | 0.311 | Thymidine phosphorylase inhibitor | 0.225 0.002 DBMET00485 0.284 0.001 DBMET00496 0.225 0.002 DBMET03265 0.036 0.008 DBMET00493 0.112 0.003 DB00171 0.11 0.003 DBMET00499 0.157 0.002 DBMET00498 0.049 0.005 DB11100 | ||
| 0.359 | 0.052 | 0.359 | Apoptosis antagonist | 0.295 0.089 DBMET00485 0.31 0.079 DBMET00496 0.295 0.089 DBMET03265 | ||
| 0.307 | 0.003 | 0.307 | Adenylate cyclase stimulant | 0.302 0.003 DBMET00485 0.248 0.004 DBMET00496 0.302 0.003 DBMET03265 0.147 0.067 DBMET00493 0.242 0.004 DB00171 0.144 0.073 DBMET00499 0.128 0.105 DBMET00498 | ||
| 0.303 | 0.008 | 0.65 | Expectorant | 0.419 0.005 DBMET00485 0.153 0.034 DBMET00496 0.419 0.005 DBMET03265 0.65 0.002 DB00171 | DB00171 | |
| 0.367 | 0.074 | 0.556 | Toll-Like receptor agonist | 0.507 0.03 DBMET00493 0.556 0.023 DBMET00499 | DBMET00499 | |
| 0.396 | 0.113 | 0.588 | Caspase 9 stimulant | 0.588 0.038 DBMET00485 0.384 0.121 DBMET00496 0.588 0.038 DBMET03265 0.317 0.176 DB00171 | DBMET03265 | |
| 0.315 | 0.036 | 0.315 | Anticonvulsant | 0.164 0.113 DBMET00485 0.164 0.113 DBMET03265 | ||
| 0.281 | 0.004 | 0.281 | Histamine N-methyltransferase inhibitor | 0.135 0.02 DBMET00485 0.119 0.03 DBMET00496 0.135 0.02 DBMET03265 0.114 0.034 DBMET00493 0.083 0.064 DB00171 0.077 0.07 DBMET00499 | ||
| 0.29 | 0.013 | 0.421 | Alkylator | 0.421 0.007 DBMET00485 0.326 0.011 DBMET00496 0.421 0.007 DBMET03265 0.11 0.077 DBMET00493 0.315 0.012 DB00171 0.128 0.061 DBMET00499 | DBMET03265 | |
| 0.281 | 0.005 | 0.647 | Ribonucleotide reductase inhibitor | 0.435 0.002 DBMET00485 0.165 0.01 DBMET00496 0.435 0.002 DBMET03265 0.647 0.001 DB00171 | DB00171 | |
| 0.388 | 0.12 | 0.398 | Apoptosis agonist | 0.398 0.115 DBMET00485 0.318 0.16 DBMET00496 0.398 0.115 DBMET03265 0.284 0.184 DB00171 | DBMET03265 | |
| 0.308 | 0.046 | 0.308 | Angiogenesis stimulant | 0.258 0.066 DBMET00485 0.259 0.066 DBMET00496 0.258 0.066 DBMET03265 0.157 0.118 DB00171 | ||
| 0.4 | 0.139 | 0.4 | Antiinflammatory | |||
| 0.343 | 0.085 | 0.566 | Toll-Like receptor 7 agonist | 0.516 0.029 DBMET00493 0.566 0.021 DBMET00499 | DBMET00499 | |
| 0.257 | 0.001 | 0.476 | AICAR transformylase inhibitor | 0.476 0 DBMET00485 0.223 0.001 DBMET00496 0.476 0 DBMET03265 0.119 0.004 DBMET00493 0.301 0.001 DB00171 0.147 0.003 DBMET00499 0.072 0.009 DBMET00498 | DBMET03265 | |
| 0.26 | 0.004 | 0.369 | Transcription factor STAT6 inhibitor | 0.369 0.003 DBMET00485 0.119 0.063 DBMET00496 0.369 0.003 DBMET03265 0.216 0.005 DB00171 | DBMET03265 | |
| 0.309 | 0.067 | 0.322 | Interleukin 2 agonist | 0.322 0.06 DBMET00496 | DBMET00496 | |
| 0.25 | 0.023 | 0.312 | Alpha-N-acetylglucosaminidase inhibitor | 0.312 0.015 DBMET00496 0.196 0.035 DBMET00493 0.133 0.066 DBMET00499 0.203 0.033 DBMET00498 0.159 0.05 DB11100 | DBMET00496 | |
| 0.229 | 0.005 | 0.359 | Ribonucleoside-diphosphate reductase inhibitor | 0.357 0.003 DBMET00485 0.143 0.012 DBMET00496 0.357 0.003 DBMET03265 0.359 0.003 DB00171 | DB00171 | |
| 0.235 | 0.019 | 0.264 | Topoisomerase I inhibitor | 0.098 0.071 DBMET00485 0.264 0.015 DBMET00496 0.098 0.071 DBMET03265 | DBMET00496 | |
| 0.22 | 0.004 | 0.647 | Phosphorylase inhibitor | 0.429 0.003 DBMET00485 0.221 0.004 DBMET00496 0.429 0.003 DBMET03265 0.647 0.002 DB00171 | DB00171 | |
| 0.216 | 0.009 | 0.562 | Phosphodiesterase I inhibitor | 0.413 0.003 DBMET00485 0.305 0.005 DBMET00496 0.413 0.003 DBMET03265 0.239 0.007 DBMET00493 0.562 0.002 DB00171 0.308 0.005 DBMET00499 0.12 0.027 DBMET00498 0.131 0.022 DB11100 | DB00171 | |
| 0.299 | 0.093 | 0.367 | Calcium channel activator | 0.367 0.04 DBMET00485 0.367 0.04 DBMET03265 0.235 0.165 DBMET00493 0.31 0.082 DB00171 | DBMET03265 | |
| 0.204 | 0.001 | 0.723 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.405 0 DBMET00485 0.238 0 DBMET00496 0.405 0 DBMET03265 0.136 0.001 DBMET00493 0.723 0 DB00171 0.133 0.001 DBMET00499 0.07 0.006 DBMET00498 0.029 0.018 DB11100 | DB00171 | |
| 0.208 | 0.004 | 0.331 | Purinergic P2X2 antagonist | 0.288 0.002 DBMET00485 0.115 0.023 DBMET00496 0.288 0.002 DBMET03265 0.331 0.001 DB00171 | DB00171 | |
| 0.212 | 0.014 | 0.45 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.45 0.003 DBMET00485 0.294 0.006 DBMET00496 0.45 0.003 DBMET03265 0.082 0.077 DBMET00493 0.449 0.003 DB00171 0.099 0.055 DBMET00499 0.134 0.032 DB11100 | DBMET03265 | |
| 0.198 | 0 | 0.491 | Purinergic P2Y1 agonist | 0.368 0 DBMET00485 0.045 0.002 DBMET00496 0.368 0 DBMET03265 0.014 0.013 DBMET00493 0.491 0 DB00171 | DB00171 | |
| 0.211 | 0.016 | 0.211 | CF transmembrane conductance regulator agonist | 0.13 0.117 DBMET00496 0.192 0.027 DBMET00493 0.171 0.046 DBMET00499 | ||
| 0.221 | 0.027 | 0.333 | Insulin secretagoues | 0.241 0.021 DBMET00485 0.133 0.093 DBMET00496 0.241 0.021 DBMET03265 0.333 0.009 DB00171 | DB00171 | |
| 0.206 | 0.013 | 0.546 | DNA directed RNA polymerase inhibitor | 0.334 0.006 DBMET00485 0.152 0.023 DBMET00496 0.334 0.006 DBMET03265 0.546 0.004 DB00171 0.168 0.019 DBMET00499 0.095 0.063 DBMET00498 | DB00171 | |
| 0.194 | 0.002 | 0.784 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.784 0.001 DBMET00485 0.048 0.005 DBMET00496 0.784 0.001 DBMET03265 0.778 0.001 DB00171 | DBMET03265 | |
| 0.259 | 0.076 | 0.41 | Cardiotonic | 0.185 0.134 DBMET00485 0.269 0.07 DBMET00496 0.185 0.134 DBMET03265 0.318 0.049 DBMET00493 0.41 0.027 DBMET00499 0.215 0.106 DB11100 | DBMET00499 | |
| 0.181 | 0 | 0.181 | Purinergic P2Y15 antagonist | 0.114 0.001 DBMET00485 0.071 0.002 DBMET00496 0.114 0.001 DBMET03265 0.041 0.006 DBMET00493 0.091 0.001 DB00171 0.033 0.012 DBMET00499 0.028 0.02 DBMET00498 | ||
| 0.322 | 0.144 | 0.334 | Cyclophilin D inhibitor | 0.334 0.134 DBMET00496 | DBMET00496 | |
| 0.177 | 0.007 | 0.177 | Interferon agonist | 0.125 0.015 DBMET00485 0.125 0.015 DBMET03265 0.112 0.021 DBMET00498 | ||
| 0.177 | 0.012 | 0.219 | Transcription factor NF kappa B stimulant | 0.183 0.011 DBMET00485 0.128 0.022 DBMET00496 0.183 0.011 DBMET03265 0.219 0.008 DB00171 | DB00171 | |
| 0.238 | 0.081 | 0.297 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.297 0.027 DBMET00493 0.249 0.067 DBMET00499 0.266 0.048 DBMET00498 | DBMET00493 | |
| 0.152 | 0.002 | 0.68 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.129 0.002 DBMET00485 0.68 0 DBMET00496 0.129 0.002 DBMET03265 0.069 0.003 DBMET00493 0.045 0.004 DB00171 0.078 0.003 DBMET00499 0.047 0.004 DBMET00498 | DBMET00496 | |
| 0.154 | 0.004 | 0.952 | Purinergic P2X4 antagonist | 0.813 0.001 DBMET00485 0.09 0.005 DBMET00496 0.813 0.001 DBMET03265 0.952 0.001 DB00171 | DB00171 | |
| 0.168 | 0.018 | 0.168 | AMP-activated protein kinase stimulant | 0.126 0.044 DBMET00485 0.154 0.026 DBMET00496 0.126 0.044 DBMET03265 0.148 0.029 DBMET00498 | ||
| 0.231 | 0.081 | 0.385 | Platelet antagonist | 0.307 0.05 DBMET00485 0.167 0.128 DBMET00496 0.307 0.05 DBMET03265 0.385 0.03 DB00171 | DB00171 | |
| 0.142 | 0.001 | 0.434 | Purine nucleoside phosphorylase inhibitor | 0.321 0.001 DBMET00485 0.181 0.001 DBMET00496 0.321 0.001 DBMET03265 0.076 0.001 DBMET00493 0.434 0.001 DB00171 0.035 0.002 DBMET00499 0.021 0.003 DBMET00498 | DB00171 | |
| 0.251 | 0.112 | 0.251 | Caspase 3 stimulant | |||
| 0.164 | 0.025 | 0.314 | Mucolytic | 0.19 0.016 DBMET00485 0.132 0.044 DBMET00496 0.19 0.016 DBMET03265 0.314 0.004 DB00171 | DB00171 | |
| 0.139 | 0.002 | 0.529 | Purinergic P2X agonist | 0.339 0.001 DBMET00485 0.074 0.005 DBMET00496 0.339 0.001 DBMET03265 0.529 0.001 DB00171 | DB00171 | |
| 0.183 | 0.05 | 0.228 | Amylase inhibitor | 0.228 0.035 DBMET00496 | DBMET00496 | |
| 0.197 | 0.067 | 0.197 | Hepatoprotectant | 0.139 0.122 DBMET00485 0.183 0.077 DBMET00496 0.139 0.122 DBMET03265 0.147 0.113 DB00171 | ||
| 0.13 | 0.001 | 0.13 | Isoleucine-tRNA ligase inhibitor | 0.047 0.002 DBMET00485 0.034 0.004 DBMET00496 0.047 0.002 DBMET03265 0.035 0.004 DB00171 | ||
| 0.133 | 0.004 | 0.497 | Purinergic P2T antagonist | 0.344 0.003 DBMET00485 0.041 0.01 DBMET00496 0.344 0.003 DBMET03265 0.497 0.002 DB00171 | DB00171 | |
| 0.17 | 0.047 | 0.174 | Cell wall synthesis inhibitor | 0.171 0.047 DBMET00485 0.174 0.044 DBMET00496 0.171 0.047 DBMET03265 0.135 0.08 DBMET00493 0.147 0.068 DB00171 0.117 0.103 DBMET00499 0.123 0.095 DB11100 | DBMET00496 | |
| 0.171 | 0.052 | 0.431 | Ribosomal protein S6 kinase inhibitor | 0.386 0.005 DBMET00493 0.431 0.005 DBMET00499 | DBMET00499 | |
| 0.123 | 0.007 | 0.123 | Interferon inducer | 0.096 0.014 DBMET00498 | ||
| 0.164 | 0.049 | 0.266 | MAP kinase 3 inhibitor | 0.146 0.075 DBMET00485 0.196 0.025 DBMET00496 0.146 0.075 DBMET03265 0.266 0.006 DBMET00493 0.176 0.037 DBMET00499 | DBMET00493 | |
| 0.142 | 0.026 | 0.318 | Uric acid excretion stimulant | 0.142 0.026 DBMET00496 0.153 0.022 DBMET00493 0.222 0.01 DBMET00499 0.318 0.005 DBMET00498 | DBMET00498 | |
| 0.117 | 0.002 | 0.389 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.344 0.002 DBMET00485 0.059 0.004 DBMET00496 0.344 0.002 DBMET03265 0.389 0.001 DB00171 | DB00171 | |
| 0.116 | 0.004 | 0.672 | Purinergic P2Y12 antagonist | 0.311 0.003 DBMET00485 0.037 0.01 DBMET00496 0.311 0.003 DBMET03265 0.634 0.002 DB00171 0.055 0.006 DBMET00499 0.672 0.002 DBMET00498 | DBMET00498 | |
| 0.199 | 0.09 | 0.332 | ErbB-1 antagonist | 0.332 0.025 DBMET00493 | DBMET00493 | |
| 0.175 | 0.073 | 0.175 | MAP kinase kinase 5 inhibitor | 0.153 0.14 DBMET00496 0.165 0.1 DBMET00493 | ||
| 0.137 | 0.039 | 0.137 | EphA2 antagonist | 0.126 0.049 DBMET00493 | ||
| 0.153 | 0.055 | 0.173 | MAP3K9 inhibitor | 0.13 0.095 DBMET00496 0.173 0.032 DBMET00493 0.149 0.061 DBMET00499 | DBMET00493 | |
| 0.147 | 0.05 | 0.167 | Epidermal growth factor receptor kinase inhibitor | 0.167 0.038 DBMET00493 | DBMET00493 | |
| 0.108 | 0.011 | 0.108 | Protein 50S ribosomal subunit inhibitor | 0.099 0.013 DBMET00485 0.087 0.017 DBMET00496 0.099 0.013 DBMET03265 0.087 0.017 DB00171 | ||
| 0.154 | 0.064 | 0.154 | Hemostatic | |||
| 0.116 | 0.031 | 0.324 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.274 0.005 DBMET00485 0.067 0.065 DBMET00496 0.274 0.005 DBMET03265 0.324 0.004 DB00171 | DB00171 | |
| 0.126 | 0.042 | 0.126 | Cyclin-dependent kinase 9 inhibitor | 0.09 0.076 DBMET00485 0.09 0.076 DBMET03265 0.1 0.063 DBMET00493 | ||
| 0.104 | 0.021 | 0.104 | T cell inhibitor | 0.1 0.025 DBMET00496 | ||
| 0.117 | 0.035 | 0.231 | Protein kinase A inhibitor | 0.076 0.064 DBMET00496 0.231 0.01 DBMET00493 0.077 0.063 DBMET00499 | DBMET00493 | |
| 0.113 | 0.032 | 0.164 | Phosphodiesterase 6D inhibitor | 0.164 0.007 DBMET00496 0.093 0.068 DBMET00493 0.1 0.053 DBMET00499 | DBMET00496 | |
| 0.083 | 0.002 | 0.104 | Guanylate cyclase inhibitor | 0.096 0.001 DBMET00485 0.073 0.004 DBMET00496 0.096 0.001 DBMET03265 0.104 0.001 DB00171 | DB00171 | |
| 0.125 | 0.045 | 0.556 | Xanthine oxidase inhibitor | 0.19 0.022 DBMET00496 0.268 0.01 DBMET00493 0.306 0.007 DBMET00499 0.556 0.003 DBMET00498 | DBMET00498 | |
| 0.085 | 0.005 | 0.651 | HCV NS5B polymerase inhibitor | 0.308 0.003 DBMET00485 0.048 0.011 DBMET00496 0.308 0.003 DBMET03265 0.651 0.002 DB00171 | DB00171 | |
| 0.093 | 0.017 | 0.102 | Protein kinase C beta inhibitor | 0.102 0.013 DBMET00496 0.072 0.044 DBMET00493 | DBMET00496 | |
| 0.179 | 0.103 | 0.622 | EphB2 antagonist | 0.622 0.004 DBMET00493 0.476 0.009 DBMET00499 | DBMET00493 | |
| 0.094 | 0.019 | 0.094 | Phosphodiesterase VIII inhibitor | 0.069 0.056 DBMET00485 0.069 0.056 DBMET03265 | ||
| 0.097 | 0.023 | 0.47 | Purinergic P2 antagonist | 0.353 0.004 DBMET00485 0.07 0.039 DBMET00496 0.353 0.004 DBMET03265 0.47 0.004 DB00171 0.055 0.053 DBMET00499 0.214 0.006 DBMET00498 | DB00171 | |
| 0.093 | 0.019 | 0.1 | MAP kinase kinase 7 inhibitor | 0.1 0.013 DBMET00493 0.085 0.034 DBMET00499 0.081 0.044 DBMET00498 | DBMET00493 | |
| 0.174 | 0.102 | 0.31 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.17 0.106 DBMET00485 0.17 0.106 DBMET03265 0.31 0.027 DBMET00493 0.144 0.143 DBMET00499 | DBMET00493 | |
| 0.192 | 0.121 | 0.192 | Hypoglycemic | 0.189 0.123 DBMET00496 | ||
| 0.076 | 0.005 | 0.076 | Cytokine production stimulant | 0.05 0.029 DBMET00485 0.05 0.029 DBMET03265 | ||
| 0.107 | 0.037 | 0.107 | ErbB-3 antagonist | |||
| 0.066 | 0 | 0.116 | Methylmalonyl-CoA mutase inhibitor | 0.104 0 DBMET00485 0.034 0.002 DBMET00496 0.104 0 DBMET03265 0.02 0.008 DBMET00493 0.116 0 DB00171 0.017 0.015 DBMET00499 | DB00171 | |
| 0.098 | 0.036 | 0.192 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.174 0.008 DBMET00493 0.192 0.006 DBMET00499 | DBMET00499 | |
| 0.062 | 0.002 | 0.758 | Purinergic receptor agonist | 0.169 0.001 DBMET00485 0.054 0.003 DBMET00496 0.169 0.001 DBMET03265 0.758 0.001 DB00171 | DB00171 | |
| 0.062 | 0.002 | 0.758 | Purinergic P2 agonist | 0.169 0.001 DBMET00485 0.054 0.003 DBMET00496 0.169 0.001 DBMET03265 0.758 0.001 DB00171 | DB00171 | |
| 0.108 | 0.051 | 0.178 | Folate antagonist | 0.178 0.014 DBMET00485 0.178 0.014 DBMET03265 0.125 0.035 DB00171 | DBMET03265 | |
| 0.181 | 0.125 | 0.295 | Nitric-oxide synthase stimulant | 0.295 0.013 DBMET00493 0.277 0.018 DBMET00499 0.206 0.079 DBMET00498 | DBMET00493 | |
| 0.062 | 0.008 | 0.062 | Antibiotic Aminoglycoside-like | 0.049 0.014 DBMET00485 0.054 0.011 DBMET00496 0.049 0.014 DBMET03265 0.045 0.017 DB00171 | ||
| 0.062 | 0.01 | 0.062 | Arginase inhibitor | 0.042 0.021 DBMET00496 | ||
| 0.052 | 0.002 | 0.749 | Purinergic P2Y agonist | 0.153 0.001 DBMET00485 0.046 0.003 DBMET00496 0.153 0.001 DBMET03265 0.749 0 DB00171 | DB00171 | |
| 0.077 | 0.026 | 0.149 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.149 0.007 DBMET00485 0.149 0.007 DBMET03265 0.147 0.007 DB00171 | DBMET03265 | |
| 0.084 | 0.035 | 0.087 | Selectin antagonist | 0.087 0.033 DBMET00496 | DBMET00496 | |
| 0.059 | 0.01 | 0.575 | RNA-directed RNA polymerase inhibitor | 0.178 0.004 DBMET00485 0.032 0.027 DBMET00496 0.178 0.004 DBMET03265 0.575 0.002 DB00171 | DB00171 | |
| 0.055 | 0.009 | 0.216 | Purinergic P2Y2 antagonist | 0.161 0.002 DBMET00485 0.046 0.012 DBMET00496 0.161 0.002 DBMET03265 0.216 0.001 DB00171 | DB00171 | |
| 0.144 | 0.098 | 0.145 | Interleukin 6 antagonist | 0.145 0.096 DBMET00485 0.145 0.096 DBMET03265 0.142 0.101 DB11100 | DBMET03265 | |
| 0.136 | 0.089 | 0.232 | Acetylcholine M1 receptor antagonist | 0.147 0.077 DBMET00485 0.17 0.058 DBMET00496 0.147 0.077 DBMET03265 0.232 0.03 DB00171 | DB00171 | |
| 0.091 | 0.046 | 0.101 | mTOR complex 2 inhibitor | 0.101 0.032 DBMET00493 0.09 0.047 DBMET00499 | DBMET00493 | |
| 0.048 | 0.004 | 0.242 | Purinergic P2Y1 antagonist | 0.231 0.002 DBMET00485 0.015 0.012 DBMET00496 0.231 0.002 DBMET03265 0.242 0.002 DB00171 | DB00171 | |
| 0.064 | 0.022 | 0.071 | Adenine nucleotide translocase inhibitor | 0.071 0.014 DBMET00485 0.066 0.019 DBMET00496 0.071 0.014 DBMET03265 0.063 0.023 DB00171 | DBMET03265 | |
| 0.059 | 0.017 | 0.059 | Mannosidase inhibitor | 0.054 0.021 DBMET00496 | ||
| 0.06 | 0.018 | 0.133 | Thymidylate synthase inhibitor | 0.133 0.003 DBMET00485 0.079 0.008 DBMET00496 0.133 0.003 DBMET03265 0.063 0.015 DBMET00493 0.068 0.013 DB00171 0.075 0.009 DBMET00499 0.081 0.007 DBMET00498 | DBMET03265 | |
| 0.064 | 0.022 | 0.064 | Alpha-mannosidase inhibitor | 0.062 0.024 DBMET00496 | ||
| 0.049 | 0.009 | 0.076 | Uridine phosphorylase inhibitor | 0.067 0.004 DBMET00485 0.076 0.004 DBMET00496 0.067 0.004 DBMET03265 0.029 0.018 DB00171 0.033 0.015 DBMET00499 0.056 0.006 DBMET00498 0.04 0.012 DB11100 | DBMET00496 | |
| 0.038 | 0.001 | 0.451 | Purinergic P2Y2 agonist | 0.262 0 DBMET00485 0.028 0.001 DBMET00496 0.262 0 DBMET03265 0.451 0 DB00171 | DB00171 | |
| 0.091 | 0.053 | 0.091 | Epidermal growth factor antagonist | 0.083 0.062 DBMET00493 | ||
| 0.054 | 0.019 | 0.12 | Geranyltranstransferase inhibitor | 0.085 0.004 DBMET00485 0.085 0.004 DBMET03265 0.12 0.003 DB00171 | DB00171 | |
| 0.036 | 0.004 | 0.178 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.178 0.001 DBMET00496 0.048 0.003 DBMET00493 0.066 0.002 DBMET00499 0.034 0.004 DBMET00498 | DBMET00496 | |
| 0.055 | 0.023 | 0.098 | Glucose-6-phosphate isomerase inhibitor | 0.098 0.005 DBMET00485 0.054 0.024 DBMET00496 0.098 0.005 DBMET03265 0.063 0.016 DB00171 0.044 0.04 DBMET00498 | DBMET03265 | |
| 0.171 | 0.141 | 0.171 | Antioxidant | 0.16 0.153 DBMET00496 | ||
| 0.116 | 0.091 | 0.565 | Interleukin 4 antagonist | 0.565 0.004 DBMET00498 | DBMET00498 | |
| 0.029 | 0.003 | 0.232 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.021 0.006 DBMET00485 0.042 0.002 DBMET00496 0.021 0.006 DBMET03265 0.232 0.001 DBMET00493 0.019 0.008 DB00171 0.062 0.001 DBMET00499 0.037 0.002 DBMET00498 | DBMET00493 | |
| 0.114 | 0.089 | 0.115 | Cyclin-dependent kinase 7 inhibitor | 0.115 0.089 DBMET00493 | DBMET00493 | |
| 0.135 | 0.112 | 0.135 | Nitric oxide antagonist | 0.135 0.112 DBMET00496 | ||
| 0.059 | 0.038 | 0.369 | Phosphatidylinositol 3-kinase delta inhibitor | 0.369 0.004 DBMET00493 0.073 0.028 DBMET00499 | DBMET00493 | |
| 0.032 | 0.012 | 0.032 | Sodium/glucose cotransporter 2 inhibitor | 0.029 0.014 DBMET00496 | ||
| 0.111 | 0.092 | 0.289 | Protein-tyrosine kinase Lyn inhibitor | 0.289 0.021 DBMET00493 0.139 0.072 DBMET00499 | DBMET00493 | |
| 0.104 | 0.086 | 0.368 | c-Src kinase inhibitor | 0.212 0.032 DBMET00485 0.212 0.032 DBMET03265 0.368 0.01 DBMET00493 0.181 0.041 DB00171 0.195 0.037 DBMET00499 | DBMET00493 | |
| 0.067 | 0.049 | 0.067 | Protein kinase C alpha inhibitor | |||
| 0.089 | 0.073 | 0.105 | Ephrin antagonist | 0.103 0.061 DBMET00493 0.105 0.059 DBMET00499 | DBMET00499 | |
| 0.082 | 0.067 | 0.108 | Hematopoietic | 0.108 0.029 DBMET00485 0.102 0.034 DBMET00496 0.108 0.029 DBMET03265 0.081 0.07 DB00171 | DBMET03265 | |
| 0.091 | 0.076 | 0.155 | Anabolic | 0.135 0.027 DBMET00485 0.135 0.027 DBMET03265 0.155 0.015 DB00171 | DB00171 | |
| 0.028 | 0.014 | 0.033 | Sodium/glucose cotransporter inhibitor | 0.033 0.009 DBMET00496 | DBMET00496 | |
| 0.083 | 0.07 | 0.193 | Triose-phosphate isomerase inhibitor | 0.193 0.012 DBMET00485 0.095 0.053 DBMET00496 0.193 0.012 DBMET03265 0.085 0.068 DBMET00493 0.099 0.049 DB00171 0.086 0.065 DB11100 | DBMET03265 | |
| 0.087 | 0.075 | 0.095 | Aminopeptidase B inhibitor | 0.095 0.069 DB11100 | DB11100 | |
| 0.119 | 0.108 | 0.373 | Src kinase inhibitor | 0.194 0.057 DBMET00485 0.194 0.057 DBMET03265 0.373 0.015 DBMET00493 0.17 0.071 DB00171 0.181 0.064 DBMET00499 | DBMET00493 | |
| 0.049 | 0.039 | 0.164 | Antiviral (Hepatitis D) | 0.088 0.006 DBMET00485 0.088 0.006 DBMET03265 0.164 0.003 DB00171 | DB00171 | |
| 0.127 | 0.117 | 0.127 | Interferon gamma antagonist | |||
| 0.052 | 0.043 | 0.067 | Glucosylceramidase inhibitor | 0.067 0.024 DBMET00496 0.064 0.026 DBMET00498 | DBMET00496 | |
| 0.023 | 0.018 | 0.023 | Protein 30S ribosomal subunit inhibitor | |||
| 0.005 | 0.001 | 0.047 | Purinergic P2Y6 agonist | 0.018 0 DBMET00485 0.007 0.001 DBMET00496 0.018 0 DBMET03265 0.047 0 DB00171 | DB00171 | |
| 0.036 | 0.033 | 0.037 | Toll-Like receptor 2 agonist | 0.037 0.033 DBMET00496 | DBMET00496 | |
| 0.004 | 0.003 | 0.199 | Purinergic P2Y4 agonist | 0.016 0.001 DBMET00485 0.005 0.003 DBMET00496 0.016 0.001 DBMET03265 0.199 0 DB00171 | DB00171 | |
| 0.049 | 0.05 | 0.394 | Phosphodiesterase II inhibitor | 0.067 0.026 DBMET00493 0.117 0.008 DBMET00499 0.394 0.002 DBMET00498 | DBMET00498 | |
| 0.065 | 0.066 | 0.203 | Protein kinase B gamma inhibitor | 0.076 0.051 DBMET00499 0.203 0.008 DBMET00498 | DBMET00498 | |
| 0.067 | 0.068 | 0.079 | Antineoplastic antibiotic | 0.079 0.058 DBMET00496 | DBMET00496 | |
| 0.065 | 0.067 | 0.074 | ErbB-2 antagonist | 0.074 0.054 DBMET00493 | DBMET00493 | |
| 0.08 | 0.084 | 0.568 | Cyclin-dependent kinase 1 inhibitor | 0.568 0.004 DBMET00493 0.308 0.011 DBMET00499 | DBMET00493 | |
| 0.043 | 0.047 | 0.385 | Phosphodiesterase 2A inhibitor | 0.051 0.032 DBMET00493 0.096 0.009 DBMET00499 0.385 0.002 DBMET00498 | DBMET00498 | |
| 0.138 | 0.142 | 0.215 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.183 0.104 DBMET00493 0.215 0.084 DBMET00499 | DBMET00499 | |
| 0.097 | 0.106 | 0.201 | Lck kinase inhibitor | 0.111 0.092 DBMET00485 0.111 0.092 DBMET03265 0.201 0.04 DBMET00493 0.103 0.099 DBMET00499 | DBMET00493 | |
| 0.018 | 0.032 | 0.044 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.044 0.004 DBMET00485 0.044 0.004 DBMET03265 0.022 0.02 DB00171 | DBMET03265 | |
| 0.048 | 0.07 | 0.056 | Heat shock protein 90 beta antagonist | 0.056 0.047 DBMET00493 | DBMET00493 | |
| 0.05 | 0.073 | 0.36 | HIV-1 reverse transcriptase inhibitor | 0.132 0.018 DBMET00485 0.132 0.018 DBMET03265 0.36 0.005 DB00171 0.118 0.023 DBMET00498 | DB00171 | |
| 0.061 | 0.087 | 0.112 | Phosphodiesterase VI inhibitor | 0.112 0.014 DBMET00496 0.096 0.023 DBMET00493 0.086 0.033 DBMET00499 | DBMET00496 | |
| 0.032 | 0.06 | 0.086 | Fructose-1,6-bisphosphatase inhibitor | 0.086 0.005 DBMET00485 0.086 0.005 DBMET03265 0.04 0.039 DB00171 | DBMET03265 | |
| 0.127 | 0.164 | 0.214 | Dyrk kinase inhibitor | 0.187 0.106 DBMET00493 0.214 0.091 DBMET00499 | DBMET00499 | |
| 0.049 | 0.088 | 0.086 | Protein kinase B alpha inhibitor | 0.086 0.037 DBMET00493 | DBMET00493 | |
| 0.037 | 0.081 | 0.521 | CDK1/cyclin B inhibitor | 0.058 0.049 DBMET00496 0.521 0.004 DBMET00493 0.094 0.027 DBMET00499 | DBMET00493 | |
| 0.124 | 0.169 | 0.206 | Platelet aggregation inhibitor | 0.147 0.132 DBMET00485 0.147 0.132 DBMET03265 0.206 0.077 DBMET00493 0.17 0.107 DBMET00499 | DBMET00493 | |
| 0.046 | 0.091 | 0.123 | Corticotropin releasing factor 2 receptor antagonist | 0.086 0.013 DBMET00485 0.086 0.013 DBMET03265 0.065 0.036 DBMET00493 0.123 0.004 DB00171 0.076 0.021 DBMET00499 | DB00171 | |
| 0.054 | 0.103 | 0.093 | Bcr-Abl kinase inhibitor | 0.093 0.049 DBMET00493 | DBMET00493 | |
| 0.133 | 0.185 | 0.247 | Growth factor agonist | 0.247 0.033 DBMET00493 | DBMET00493 | |
| 0.09 | 0.143 | 0.119 | Protein kinase C nu inhibitor | 0.119 0.094 DBMET00499 | DBMET00499 | |
| 0.102 | 0.157 | 0.123 | NOS3 expression enhancer | 0.123 0.11 DBMET00496 | DBMET00496 | |
| 0.1 | 0.155 | 0.18 | CDC-like kinase 4 inhibitor | 0.156 0.096 DBMET00493 0.18 0.079 DBMET00499 | DBMET00499 | |
| 0.129 | 0.186 | 0.164 | Spasmolytic | 0.164 0.15 DB00171 | DB00171 | |
| 0.021 | 0.078 | 0.079 | Purinergic P2X3 antagonist | 0.042 0.015 DBMET00485 0.042 0.015 DBMET03265 0.079 0.005 DB00171 | DB00171 | |
| 0.029 | 0.091 | 0.055 | Bruton tyrosine kinase inhibitor | 0.055 0.041 DBMET00493 | DBMET00493 | |
| 0.002 | 0.067 | 0.035 | DNA polymerase III subunit alpha inhibitor | 0.011 0.003 DBMET00493 0.018 0.002 DBMET00499 0.035 0.001 DBMET00498 | DBMET00498 | |
| 0.042 | 0.112 | 0.09 | CDK2/cyclin E2 inhibitor | 0.09 0.032 DBMET00493 | DBMET00493 | |
| 0.003 | 0.073 | 0.007 | Phosphoribosylglycinamide formyltransferase inhibitor | 0.007 0.006 DBMET00498 | DBMET00498 | |
| 0.072 | 0.143 | 0.112 | Multidrug resistance-associated protein 1 inhibitor | 0.112 0.059 DBMET00493 | DBMET00493 | |
| 0.06 | 0.134 | 0.177 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.177 0.035 DBMET00493 | DBMET00493 | |
| 0.06 | 0.134 | 0.177 | Abl kinase inhibitor | 0.177 0.035 DBMET00493 | DBMET00493 | |
| 0.013 | 0.091 | 0.031 | Potassium channel small-conductance Ca-activated activator | 0.031 0.022 DBMET00493 | DBMET00493 | |
| 0.062 | 0.141 | 0.311 | Phosphodiesterase 7B inhibitor | 0.205 0.01 DBMET00493 0.311 0.004 DBMET00499 | DBMET00499 | |
| 0.029 | 0.109 | 0.046 | CF transmembrane conductance regulator antagonist | 0.046 0.013 DBMET00496 0.038 0.034 DBMET00493 | DBMET00496 | |
| 0.062 | 0.146 | 0.101 | Lanosterol 14 alpha demethylase inhibitor | 0.087 0.076 DBMET00496 0.101 0.054 DBMET00493 | DBMET00493 | |
| 0.118 | 0.203 | 0.142 | Ca2+-transporting ATPase inhibitor | 0.142 0.066 DBMET00493 0.13 0.122 DBMET00499 0.132 0.108 DBMET00498 | DBMET00493 | |
| 0.018 | 0.107 | 0.973 | Phosphodiesterase 3B inhibitor | 0.045 0.03 DBMET00496 0.205 0.005 DBMET00493 0.266 0.004 DBMET00499 0.973 0.001 DBMET00498 | DBMET00498 | |
| 0.02 | 0.115 | 0.295 | Xanthine dehydrogenase inhibitor | 0.1 0.016 DBMET00493 0.154 0.007 DBMET00499 0.295 0.003 DBMET00498 | DBMET00498 | |
| 0.087 | 0.183 | 0.35 | Psychostimulant | 0.35 0.031 DBMET00485 0.35 0.031 DBMET03265 0.15 0.117 DBMET00493 0.256 0.056 DB00171 | DBMET03265 | |
| 0.034 | 0.137 | 0.455 | CDK1/cyclin B1 inhibitor | 0.129 0.02 DBMET00496 0.455 0.004 DBMET00493 0.093 0.031 DBMET00499 0.062 0.058 DBMET00498 | DBMET00493 | |
| 0.06 | 0.163 | 0.38 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.38 0.009 DBMET00498 | DBMET00498 | |
| 0.017 | 0.122 | 0.039 | Toll-Like receptor 4 agonist | 0.039 0.005 DBMET00485 0.039 0.005 DBMET03265 0.032 0.009 DB00171 | DBMET03265 | |
| 0.025 | 0.129 | 0.052 | EphB4 antagonist | 0.052 0.047 DBMET00499 | DBMET00499 | |
| 0.042 | 0.152 | 0.487 | Phosphodiesterase 3A inhibitor | 0.079 0.056 DBMET00496 0.192 0.009 DBMET00493 0.185 0.01 DBMET00499 0.487 0.003 DBMET00498 | DBMET00498 | |
| 0.025 | 0.145 | 0.641 | Cyclin B inhibitor | 0.641 0.003 DBMET00493 0.231 0.004 DBMET00499 | DBMET00493 | |
| 0.004 | 0.125 | 0.058 | Egl nine homolog 2 inhibitor | 0.058 0.003 DBMET00493 0.024 0.004 DBMET00499 | DBMET00493 | |
| 0.027 | 0.148 | 0.09 | Phosphatidylinositol kinase inhibitor | 0.09 0.024 DBMET00493 | DBMET00493 | |
| 0.025 | 0.149 | 0.106 | Cyclin A2 inhibitor | 0.106 0.023 DBMET00493 0.065 0.043 DBMET00499 | DBMET00493 | |
| 0.036 | 0.16 | 0.138 | Protein kinase B beta inhibitor | 0.138 0.009 DBMET00493 0.12 0.015 DBMET00499 0.069 0.058 DBMET00498 | DBMET00493 | |
| 0.159 | 0.285 | 0.188 | MAP kinase kinase 3 inhibitor | 0.188 0.163 DBMET00493 | DBMET00493 | |
| 0.08 | 0.207 | 0.262 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.262 0.044 DBMET00499 | DBMET00499 | |
| 0.034 | 0.162 | 0.263 | MAP3K7 inhibitor | 0.263 0.004 DBMET00493 | DBMET00493 | |
| 0.005 | 0.135 | 0.018 | Glucose-dependent insulinotropic receptor antagonist | 0.018 0.004 DBMET00493 | DBMET00493 | |
| 0.056 | 0.19 | 0.123 | Electrolyte absorption antagonist | 0.119 0.037 DBMET00493 0.113 0.043 DBMET00499 0.123 0.034 DB11100 | DB11100 | |
| 0.019 | 0.155 | 0.396 | Nicotinic acid receptor 1 agonist | 0.396 0.002 DBMET00496 0.162 0.004 DBMET00493 0.207 0.004 DBMET00499 | DBMET00496 | |
| 0.135 | 0.273 | 0.312 | Transcription factor STAT inhibitor | 0.312 0.049 DBMET00485 0.312 0.049 DBMET03265 | DBMET03265 | |
| 0.019 | 0.163 | 0.7 | Cyclin B2 inhibitor | 0.7 0.002 DBMET00493 0.25 0.004 DBMET00499 | DBMET00493 | |
| 0.082 | 0.227 | 0.193 | Polo-like kinase-3 inhibitor | 0.123 0.12 DBMET00485 0.123 0.12 DBMET03265 0.193 0.049 DBMET00499 | DBMET00499 | |
| 0.058 | 0.208 | 0.115 | Toll-Like receptor 4 antagonist | 0.115 0.049 DBMET00485 0.115 0.049 DBMET03265 0.09 0.088 DB00171 | DBMET03265 | |
| 0.053 | 0.203 | 0.153 | Protein kinase C gamma inhibitor | 0.153 0.03 DBMET00493 | DBMET00493 | |
| 0.076 | 0.227 | 0.124 | Heat shock protein 90 antagonist | 0.124 0.108 DBMET00493 | DBMET00493 | |
| 0.036 | 0.188 | 0.077 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.077 0.075 DBMET00493 | DBMET00493 | |
| 0.085 | 0.24 | 0.259 | I kappa B kinase epsilon inhibitor | 0.259 0.033 DBMET00493 | DBMET00493 | |
| 0.039 | 0.195 | 0.183 | Cyclin-dependent kinase 5 inhibitor | 0.183 0.027 DBMET00493 0.124 0.055 DBMET00499 | DBMET00493 | |
| 0.066 | 0.222 | 0.199 | Clk dual-specificity kinase inhibitor | 0.194 0.083 DBMET00493 0.199 0.08 DBMET00499 | DBMET00499 | |
| 0.071 | 0.228 | 0.301 | Diuretic | 0.208 0.041 DBMET00493 0.301 0.022 DBMET00499 | DBMET00499 | |
| 0.023 | 0.18 | 0.723 | Cyclin B1 inhibitor | 0.723 0.002 DBMET00493 0.274 0.004 DBMET00499 | DBMET00493 | |
| 0.03 | 0.189 | 0.175 | TIE-2 antagonist | 0.175 0.018 DBMET00493 | DBMET00493 | |
| 0.02 | 0.182 | 0.093 | Cyclin A inhibitor | 0.093 0.025 DBMET00493 0.055 0.048 DBMET00499 | DBMET00493 | |
| 0.057 | 0.222 | 0.12 | mTOR complex 1 inhibitor | 0.112 0.04 DBMET00493 0.12 0.029 DBMET00499 | DBMET00499 | |
| 0.03 | 0.196 | 0.178 | TIE antagonist | 0.178 0.018 DBMET00493 | DBMET00493 | |
| 0.021 | 0.188 | 0.05 | mTOR inhibitor | 0.046 0.043 DBMET00493 0.05 0.038 DBMET00499 | DBMET00499 | |
| 0.044 | 0.212 | 0.38 | GABA C receptor agonist | 0.38 0.005 DBMET00493 0.26 0.013 DBMET00499 0.257 0.013 DBMET00498 0.177 0.025 DB11100 | DBMET00493 | |
| 0.001 | 0.168 | 0.016 | Mannitol 2-dehydrogenase inhibitor | 0.016 0.003 DBMET00485 0.016 0.003 DBMET03265 0.009 0.005 DB00171 | DBMET03265 | |
| 0.086 | 0.254 | 0.165 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.165 0.099 DBMET00499 | DBMET00499 | |
| 0.015 | 0.185 | 0.032 | LIM domain kinase 2 inhibitor | 0.032 0.019 DBMET00493 | DBMET00493 | |
| 0.129 | 0.3 | 0.593 | DNA directed DNA polymerase inhibitor | 0.277 0.175 DBMET00485 0.277 0.175 DBMET03265 0.593 0.057 DB00171 0.328 0.149 DBMET00499 0.5 0.082 DBMET00498 | DB00171 | |
| 0.017 | 0.189 | 0.063 | HIV-1 integrase (Strand Transfer) inhibitor | 0.063 0.04 DBMET00485 0.063 0.04 DBMET03265 | DBMET03265 | |
| 0.073 | 0.25 | 0.144 | Cyclin-dependent kinase 8 inhibitor | 0.121 0.116 DBMET00493 0.144 0.086 DBMET00499 | DBMET00499 | |
| 0.023 | 0.202 | 0.124 | Histidine decarboxylase inhibitor | 0.124 0.025 DBMET00493 0.079 0.043 DBMET00499 0.074 0.047 DB11100 | DBMET00493 | |
| 0.082 | 0.262 | 0.275 | Tumour necrosis factor antagonist | 0.231 0.037 DBMET00499 0.275 0.024 DB11100 | DB11100 | |
| 0.017 | 0.197 | 0.116 | Alcohol oxidase inhibitor | 0.116 0.015 DBMET00493 0.082 0.023 DBMET00499 0.053 0.042 DBMET00498 0.106 0.017 DB11100 | DBMET00493 | |
| 0.064 | 0.248 | 0.541 | Pyruvate kinase inhibitor | 0.396 0.021 DBMET00485 0.396 0.021 DBMET03265 0.541 0.006 DB00171 | DB00171 | |
| 0.03 | 0.214 | 0.06 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.06 0.043 DB00171 | DB00171 | |
| 0.02 | 0.207 | 0.064 | HIV-1 integrase (3'-Processing) inhibitor | 0.064 0.043 DBMET00485 0.064 0.043 DBMET03265 | DBMET03265 | |
| 0.05 | 0.237 | 0.125 | CDC-like kinase 2 inhibitor | 0.125 0.114 DBMET00493 | DBMET00493 | |
| 0.076 | 0.269 | 0.692 | Aldehyde oxidase inhibitor | 0.57 0.023 DBMET00493 0.692 0.009 DBMET00499 0.178 0.118 DB11100 | DBMET00499 | |
| 0.016 | 0.215 | 0.032 | ATR kinase inhibitor | 0.032 0.026 DBMET00493 | DBMET00493 | |
| 0.048 | 0.246 | 0.165 | Interleukin 5 antagonist | 0.165 0.008 DBMET00498 | DBMET00498 | |
| 0.036 | 0.242 | 0.18 | Protein kinase (CK1) inhibitor | 0.18 0.048 DBMET00493 0.149 0.068 DBMET00499 | DBMET00493 | |
| 0.035 | 0.247 | 0.194 | Glycogen synthase kinase-3 alpha inhibitor | 0.128 0.079 DBMET00493 0.194 0.043 DBMET00499 | DBMET00499 | |
| 0.043 | 0.257 | 0.166 | MAP kinase kinase 1 inhibitor | 0.166 0.011 DBMET00493 0.114 0.041 DBMET00499 0.103 0.053 DBMET00498 | DBMET00493 | |
| 0.027 | 0.241 | 0.296 | CDK/cyclin complex inhibitor | 0.296 0.01 DBMET00493 | DBMET00493 | |
| 0.014 | 0.235 | 0.055 | MAP3K5 inhibitor | 0.055 0.009 DBMET00493 | DBMET00493 | |
| 0.023 | 0.247 | 0.054 | Cyclin H inhibitor | 0.054 0.048 DBMET00493 | DBMET00493 | |
| 0.102 | 0.328 | 0.355 | Angiogenesis inhibitor | 0.355 0.069 DBMET00493 | DBMET00493 | |
| 0.044 | 0.273 | 0.338 | Tyrosine kinase inhibitor | 0.338 0.036 DBMET00493 | DBMET00493 | |
| 0.023 | 0.252 | 0.188 | Cyclin B3 inhibitor | 0.188 0.007 DBMET00493 | DBMET00493 | |
| 0.044 | 0.275 | 0.141 | Growth factor antagonist | 0.141 0.075 DBMET00493 | DBMET00493 | |
| 0.03 | 0.262 | 0.09 | Telomerase inhibitor | 0.09 0.039 DBMET00493 | DBMET00493 | |
| 0.044 | 0.278 | 0.085 | Granulocyte macrophage colony stimulating factor agonist | 0.085 0.063 DBMET00493 | DBMET00493 | |
| 0.03 | 0.265 | 0.129 | AXL receptor tyrosine kinase inhibitor | 0.129 0.024 DBMET00493 | DBMET00493 | |
| 0.021 | 0.26 | 0.287 | Tyrosine-protein kinase receptor FLT3 inhibitor | 0.287 0.021 DBMET00493 | DBMET00493 | |
| 0.029 | 0.271 | 0.371 | RET inhibitor | 0.371 0.012 DBMET00493 0.28 0.026 DBMET00499 | DBMET00493 | |
| 0.119 | 0.361 | 0.546 | GABA C receptor rho-3 antagonist | 0.546 0.015 DBMET00493 0.454 0.04 DBMET00499 0.378 0.072 DBMET00498 0.274 0.134 DB11100 | DBMET00493 | |
| 0.061 | 0.306 | 0.281 | MAP kinase kinase 2 inhibitor | 0.281 0.042 DBMET00493 0.158 0.114 DBMET00499 | DBMET00493 | |
| 0.032 | 0.282 | 0.509 | Bronchodilator | 0.334 0.008 DBMET00493 0.509 0.004 DBMET00499 | DBMET00499 | |
| 0.115 | 0.372 | 0.421 | Histamine release inhibitor | 0.229 0.172 DBMET00496 0.421 0.065 DBMET00493 0.28 0.135 DBMET00499 | DBMET00493 | |
| 0.048 | 0.31 | 0.234 | LIM domain kinase 1 inhibitor | 0.234 0.046 DBMET00493 0.202 0.062 DBMET00499 | DBMET00493 | |
| 0.037 | 0.298 | 0.178 | GABA C receptor rho-1 antagonist | 0.178 0.012 DBMET00493 0.156 0.019 DBMET00499 0.091 0.076 DBMET00498 | DBMET00493 | |
| 0.02 | 0.282 | 0.102 | Platelet growth factor antagonist | 0.102 0.039 DBMET00493 | DBMET00493 | |
| 0.017 | 0.279 | 0.126 | Phenylalanine 4-hydroxylase inhibitor | 0.1 0.026 DBMET00493 0.082 0.036 DBMET00499 0.126 0.016 DBMET00498 | DBMET00498 | |
| 0.053 | 0.327 | 0.166 | Mannose-6-phosphate isomerase inhibitor | 0.166 0.052 DBMET00485 0.166 0.052 DBMET03265 0.146 0.068 DBMET00498 | DBMET03265 | |
| 0.01 | 0.286 | 0.085 | Phosphodiesterase 4A inhibitor | 0.078 0.021 DBMET00493 0.085 0.019 DBMET00499 | DBMET00499 | |
| 0.031 | 0.315 | 0.225 | Cyclin-dependent kinase inhibitor | 0.225 0.032 DBMET00493 0.155 0.054 DBMET00499 | DBMET00493 | |
| 0.023 | 0.313 | 0.134 | Phosphodiesterase 1B inhibitor | 0.117 0.011 DBMET00493 0.134 0.008 DBMET00499 0.068 0.032 DBMET00498 | DBMET00499 | |
| 0.139 | 0.431 | 0.402 | 5 Hydroxytryptamine release inhibitor | 0.402 0.077 DBMET00493 0.243 0.238 DBMET00499 | DBMET00493 | |
| 0.02 | 0.313 | 0.109 | Fibroblast growth factor 1 antagonist | 0.109 0.051 DBMET00493 | DBMET00493 | |
| 0.041 | 0.336 | 0.174 | Activin receptor-like kinase 2 inhibitor | 0.174 0.05 DBMET00493 | DBMET00493 | |
| 0.046 | 0.341 | 0.103 | Interleukin 8 antagonist | 0.103 0.09 DBMET00499 | DBMET00499 | |
| 0.016 | 0.314 | 0.164 | Platelet activating factor beta antagonist | 0.164 0.033 DBMET00493 0.085 0.075 DBMET00499 | DBMET00493 | |
| 0.014 | 0.325 | 0.035 | Transforming growth factor beta 2 antagonist | 0.035 0.018 DBMET00493 0.034 0.021 DBMET00499 | DBMET00493 | |
| 0.015 | 0.327 | 0.087 | Leucine-rich repeat kinase 2 inhibitor | 0.087 0.052 DBMET00493 | DBMET00493 | |
| 0.028 | 0.341 | 0.176 | GABA C receptor antagonist | 0.176 0.019 DBMET00493 0.152 0.029 DBMET00499 0.124 0.049 DBMET00498 | DBMET00493 | |
| 0.055 | 0.374 | 0.214 | GABA C receptor rho-2 antagonist | 0.214 0.022 DBMET00493 0.195 0.032 DBMET00499 0.14 0.087 DBMET00498 | DBMET00493 | |
| 0.025 | 0.345 | 0.169 | Vascular endothelial growth factor 3 antagonist | 0.169 0.055 DBMET00493 | DBMET00493 | |
| 0.023 | 0.347 | 0.118 | Vascular endothelial growth factor 1 antagonist | 0.118 0.055 DBMET00493 | DBMET00493 | |
| 0.043 | 0.377 | 0.294 | Peroxidase inhibitor | 0.209 0.057 DBMET00493 0.136 0.086 DBMET00499 0.142 0.082 DBMET00498 0.294 0.038 DB11100 | DB11100 | |
| 0.014 | 0.354 | 0.974 | Phosphodiesterase III inhibitor | 0.355 0.004 DBMET00493 0.736 0.002 DBMET00499 0.974 0.001 DBMET00498 | DBMET00498 | |
| 0.005 | 0.354 | 0.059 | Dihydropteroate synthase inhibitor | 0.059 0.012 DBMET00493 0.059 0.012 DBMET00498 | DBMET00498 | |
| 0.15 | 0.502 | 0.504 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.504 0.032 DBMET00493 0.473 0.047 DBMET00499 0.344 0.158 DBMET00498 0.405 0.096 DB11100 | DBMET00493 | |
| 0.013 | 0.366 | 0.131 | Porphobilinogen synthase inhibitor | 0.131 0.025 DBMET00493 0.072 0.054 DBMET00499 | DBMET00493 | |
| 0.021 | 0.377 | 0.151 | Polo-like kinase-4 inhibitor | 0.129 0.049 DBMET00493 0.151 0.035 DBMET00499 | DBMET00499 | |
| 0.017 | 0.374 | 0.26 | Cyclin-dependent kinase 2 inhibitor | 0.26 0.016 DBMET00493 0.159 0.034 DBMET00499 | DBMET00493 | |
| 0.004 | 0.365 | 0.025 | CDK2/cyclin A3 inhibitor | 0.025 0.004 DBMET00493 | DBMET00493 | |
| 0.008 | 0.38 | 0.074 | Fibroblast growth factor 3 antagonist | 0.074 0.059 DBMET00493 | DBMET00493 | |
| 0.012 | 0.387 | 0.059 | Fibroblast growth factor 2 antagonist | 0.059 0.054 DBMET00493 | DBMET00493 | |
| 0.008 | 0.386 | 0.138 | Phosphodiesterase 4D inhibitor | 0.133 0.023 DBMET00493 0.138 0.022 DBMET00499 0.094 0.04 DBMET00498 0.133 0.023 DB11100 | DBMET00499 | |
| 0.071 | 0.455 | 0.223 | MAP-kinase-activated kinase 5 inhibitor | 0.217 0.085 DBMET00493 0.223 0.08 DBMET00499 | DBMET00499 | |
| 0.009 | 0.397 | 0.15 | Protein kinase (CK2) alpha inhibitor | 0.15 0.042 DBMET00493 0.116 0.064 DBMET00499 | DBMET00493 | |
| 0.007 | 0.399 | 0.102 | Janus tyrosine kinase 3 inhibitor | 0.102 0.032 DBMET00493 | DBMET00493 | |
| 0.021 | 0.417 | 0.116 | Creatine kinase inhibitor | 0.116 0.044 DBMET00493 | DBMET00493 | |
| 0.009 | 0.407 | 0.051 | Glutamate (mGluR1a) antagonist | 0.051 0.02 DBMET00493 | DBMET00493 | |
| 0.024 | 0.426 | 0.805 | Phosphodiesterase inhibitor | 0.292 0.016 DBMET00493 0.625 0.004 DBMET00499 0.805 0.004 DBMET00498 | DBMET00498 | |
| 0.006 | 0.409 | 0.046 | Glutamate (mGluR3) antagonist | 0.046 0.015 DBMET00498 | DBMET00498 | |
| 0.011 | 0.419 | 0.194 | Platelet activating factor alpha antagonist | 0.194 0.018 DBMET00493 | DBMET00493 | |
| 0.006 | 0.414 | 0.165 | Somatostatin 4 antagonist | 0.165 0.004 DB11100 | DB11100 | |
| 0.007 | 0.422 | 0.224 | Phosphodiesterase 4C inhibitor | 0.182 0.005 DBMET00493 0.144 0.008 DBMET00499 0.224 0.005 DBMET00498 0.117 0.011 DB11100 | DBMET00498 | |
| 0.017 | 0.432 | 0.219 | MAP kinase kinase inhibitor | 0.219 0.022 DBMET00493 0.166 0.043 DBMET00499 | DBMET00493 | |
| 0.01 | 0.438 | 0.055 | Aconitate hydratase inhibitor | 0.055 0.031 DB11100 | DB11100 | |
| 0.012 | 0.442 | 0.315 | CDK2/cyclin A inhibitor | 0.315 0.006 DBMET00493 0.115 0.046 DBMET00499 | DBMET00493 | |
| 0.01 | 0.443 | 0.059 | Histamine H4 receptor antagonist | 0.059 0.019 DBMET00493 | DBMET00493 | |
| 0.019 | 0.452 | 0.106 | MAP-kinase-activated kinase inhibitor | 0.106 0.034 DBMET00499 | DBMET00499 | |
| 0.011 | 0.444 | 0.22 | MAP kinase kinase kinase inhibitor | 0.22 0.014 DBMET00493 0.112 0.056 DBMET00499 | DBMET00493 | |
| 0.012 | 0.45 | 0.049 | Kainate receptor agonist | 0.039 0.035 DBMET00498 0.049 0.014 DB11100 | DB11100 | |
| 0.064 | 0.505 | 0.2 | Death-associated protein kinase 1 inhibitor | 0.142 0.053 DBMET00496 0.2 0.007 DBMET00493 0.143 0.052 DBMET00498 | DBMET00493 | |
| 0.008 | 0.449 | 0.347 | Check point kinase 1 inhibitor | 0.331 0.005 DBMET00493 0.347 0.005 DBMET00499 0.06 0.059 DBMET00498 0.121 0.02 DB11100 | DBMET00499 | |
| 0.017 | 0.461 | 0.138 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.138 0.072 DBMET00499 | DBMET00499 | |
| 0.008 | 0.453 | 0.086 | Syk tyrosine kinase inhibitor | 0.086 0.036 DBMET00493 | DBMET00493 | |
| 0.019 | 0.464 | 0.313 | Anesthetic general | 0.135 0.131 DBMET00499 0.313 0.03 DB11100 | DB11100 | |
| 0.014 | 0.459 | 0.081 | Phospholipase D inhibitor | 0.069 0.056 DBMET00493 0.073 0.048 DBMET00499 0.081 0.033 DBMET00498 | DBMET00498 | |
| 0.02 | 0.466 | 0.333 | Somatostatin 1 agonist | 0.333 0.002 DB11100 | DB11100 | |
| 0.032 | 0.484 | 0.115 | Interleukin 1 antagonist | 0.115 0.096 DBMET00498 | DBMET00498 | |
| 0.008 | 0.46 | 0.422 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.422 0.005 DBMET00493 0.397 0.005 DBMET00499 0.121 0.027 DB11100 | DBMET00493 | |
| 0.005 | 0.459 | 0.075 | GABA receptor antagonist | 0.075 0.024 DBMET00498 | DBMET00498 | |
| 0.013 | 0.471 | 0.328 | Glycogen synthase kinase-3 beta inhibitor | 0.328 0.011 DBMET00493 0.178 0.034 DBMET00499 | DBMET00493 | |
| 0.009 | 0.468 | 0.083 | Glutamate decarboxylase inhibitor | 0.083 0.041 DB11100 | DB11100 | |
| 0.007 | 0.466 | 0.214 | Protein kinase (CK2) inhibitor | 0.169 0.026 DBMET00493 0.214 0.016 DBMET00499 | DBMET00499 | |
| 0.013 | 0.473 | 0.335 | Glycogen synthase kinase-3 inhibitor | 0.335 0.013 DBMET00493 0.187 0.034 DBMET00499 | DBMET00493 | |
| 0.013 | 0.473 | 0.117 | Protein kinase (CK1) gamma inhibitor | 0.117 0.093 DBMET00499 | DBMET00499 | |
| 0.021 | 0.481 | 0.093 | Exportin-1 inhibitor | 0.093 0.013 DBMET00493 0.08 0.025 DBMET00499 | DBMET00493 | |
| 0.009 | 0.472 | 0.027 | Complement factor 1s inhibitor | 0.027 0.014 DBMET00493 | DBMET00493 | |
| 0.005 | 0.472 | 0.076 | GABA A receptor antagonist | 0.076 0.023 DBMET00498 | DBMET00498 | |
| 0.022 | 0.489 | 0.296 | MAP kinase 12 inhibitor | 0.188 0.026 DBMET00493 0.296 0.007 DBMET00499 0.166 0.034 DBMET00498 | DBMET00499 | |
| 0.016 | 0.486 | 0.117 | Phosphodiesterase 1A inhibitor | 0.117 0.007 DBMET00493 0.117 0.007 DBMET00499 0.062 0.036 DB11100 | DBMET00499 | |
| 0.014 | 0.484 | 0.073 | Sirtuin 1 inhibitor | 0.073 0.041 DBMET00499 | DBMET00499 | |
| 0.01 | 0.484 | 0.091 | DNA polymerase III inhibitor | 0.037 0.006 DBMET00493 0.062 0.003 DBMET00499 0.091 0.002 DBMET00498 | DBMET00498 | |
| 0 | 0.48 | 0.019 | DNA topoisomerase III inhibitor | 0.011 0.003 DBMET00499 0.019 0.002 DBMET00498 0.008 0.004 DB11100 | DBMET00498 | |
| 0.027 | 0.51 | 0.141 | Antimitotic | 0.141 0.131 DBMET00485 0.141 0.131 DBMET03265 | DBMET03265 | |
| 0.009 | 0.492 | 0.083 | Pim-1 kinase inhibitor | 0.083 0.077 DBMET00493 | DBMET00493 | |
| 0.004 | 0.489 | 0.031 | Glutaminyl-peptide cyclotransferase inhibitor | 0.023 0.013 DBMET00493 0.031 0.006 DBMET00499 | DBMET00499 | |
| 0.004 | 0.49 | 0.043 | CDK5/p25 inhibitor | 0.043 0.027 DBMET00493 0.042 0.027 DBMET00499 | DBMET00493 | |
| 0.004 | 0.492 | 0.086 | Alpha 1d adrenoreceptor agonist | 0.086 0.005 DBMET00493 0.057 0.012 DBMET00499 | DBMET00493 | |
| 0.032 | 0.521 | 0.161 | Succinate dehydrogenase inhibitor | 0.154 0.104 DBMET00493 0.161 0.093 DBMET00498 | DBMET00498 | |
| 0.013 | 0.506 | 0.181 | Vascular endothelial growth factor antagonist | 0.181 0.044 DBMET00493 | DBMET00493 | |
| 0.015 | 0.508 | 0.128 | Cystathionine beta-synthase inhibitor | 0.128 0.052 DBMET00498 | DBMET00498 | |
| 0.026 | 0.521 | 0.245 | Interleukin antagonist | 0.245 0.064 DBMET00498 | DBMET00498 | |
| 0.006 | 0.506 | 0.042 | Stearoyl-CoA desaturase inhibitor | 0.041 0.036 DBMET00493 0.042 0.033 DBMET00499 | DBMET00499 | |
| 0.014 | 0.515 | 0.062 | Histone deacetylase SIRT3 inhibitor | 0.062 0.043 DBMET00493 | DBMET00493 | |
| 0.025 | 0.526 | 0.094 | DOPA decarboxylase inhibitor | 0.094 0.089 DBMET00498 | DBMET00498 | |
| 0.012 | 0.518 | 0.083 | MAP-kinase-activated kinase 2 inhibitor | 0.083 0.041 DBMET00499 | DBMET00499 | |
| 0.001 | 0.509 | 0.031 | Egl nine homolog 3 inhibitor | 0.021 0.004 DBMET00493 0.031 0.003 DBMET00499 0.025 0.004 DBMET00498 | DBMET00499 | |
| 0.009 | 0.517 | 0.156 | Vascular endothelial growth factor 2 antagonist | 0.156 0.047 DBMET00493 | DBMET00493 | |
| 0.015 | 0.53 | 0.115 | Myeloperoxidase inhibitor | 0.115 0.022 DBMET00493 0.115 0.022 DBMET00499 | DBMET00499 | |
| 0.019 | 0.535 | 0.205 | Bone formation stimulant | 0.205 0.034 DBMET00485 0.205 0.034 DBMET03265 0.126 0.08 DB00171 | DBMET03265 | |
| 0.009 | 0.527 | 0.097 | Granulocyte macrophage colony stimulating factor antagonist | 0.093 0.08 DBMET00493 0.097 0.075 DBMET00499 | DBMET00499 | |
| 0.011 | 0.53 | 0.166 | Platelet activating factor antagonist | 0.166 0.037 DBMET00493 | DBMET00493 | |
| 0.015 | 0.542 | 0.249 | Ferrochelatase inhibitor | 0.249 0.013 DBMET00493 0.159 0.034 DBMET00499 0.146 0.039 DBMET00498 0.186 0.026 DB11100 | DBMET00493 | |
| 0.005 | 0.535 | 0.082 | Nicotinic acid receptor agonist | 0.032 0.03 DBMET00493 0.082 0.006 DBMET00499 | DBMET00499 | |
| 0.007 | 0.54 | 0.355 | Check point kinase 2 inhibitor | 0.355 0.005 DBMET00493 0.089 0.075 DBMET00499 | DBMET00493 | |
| 0.006 | 0.54 | 0.107 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | 0.107 0.051 DBMET00493 | DBMET00493 | |
| 0.02 | 0.574 | 0.158 | HIV-1 integrase (Overall Integration) inhibitor | 0.158 0.022 DBMET00498 | DBMET00498 | |
| 0.003 | 0.561 | 0.019 | Alpha 2b adrenoreceptor agonist | 0.019 0.014 DBMET00493 | DBMET00493 | |
| 0.002 | 0.565 | 0.017 | Alpha 2c adrenoreceptor agonist | 0.017 0.016 DBMET00493 | DBMET00493 | |
| 0.087 | 0.65 | 0.263 | 5 Hydroxytryptamine 3E antagonist | 0.263 0.011 DBMET00493 0.227 0.03 DBMET00499 | DBMET00493 | |
| 0.018 | 0.589 | 0.153 | Insulin sensitizer | 0.153 0.129 DBMET00493 | DBMET00493 | |
| 0.015 | 0.588 | 0.089 | Phosphodiesterase 1C inhibitor | 0.079 0.02 DBMET00493 0.089 0.014 DBMET00499 0.082 0.018 DBMET00498 0.064 0.039 DB11100 | DBMET00499 | |
| 0.005 | 0.579 | 0.585 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.585 0.004 DBMET00493 0.408 0.005 DBMET00499 | DBMET00493 | |
| 0.011 | 0.594 | 0.105 | Glutamate (mGluR4) antagonist | 0.077 0.009 DBMET00493 0.105 0.005 DBMET00499 | DBMET00499 | |
| 0.004 | 0.593 | 0.049 | Alpha 2d adrenoreceptor agonist | 0.049 0.005 DBMET00493 0.035 0.007 DBMET00499 | DBMET00493 | |
| 0.007 | 0.596 | 0.248 | Phosphodiesterase V inhibitor | 0.248 0.005 DBMET00493 0.237 0.005 DBMET00499 0.209 0.005 DBMET00498 | DBMET00493 | |
| 0.005 | 0.599 | 0.083 | Pim-3 kinase inhibitor | 0.083 0.071 DBMET00499 | DBMET00499 | |
| 0.004 | 0.6 | 0.029 | Protocollagen prolyl hydroxylase inhibitor | 0.029 0.016 DBMET00493 | DBMET00493 | |
| 0.006 | 0.603 | 0.093 | CDC7 inhibitor | 0.093 0.028 DBMET00493 0.069 0.045 DBMET00499 | DBMET00493 | |
| 0.042 | 0.64 | 0.429 | Growth hormone agonist | 0.204 0.057 DBMET00499 0.429 0.012 DB11100 | DB11100 | |
| 0.019 | 0.62 | 0.089 | Alpha 1b adrenoreceptor agonist | 0.089 0.006 DBMET00493 0.067 0.014 DBMET00499 | DBMET00493 | |
| 0.014 | 0.619 | 0.515 | Keratolytic | 0.515 0.002 DB11100 | DB11100 | |
| 0.007 | 0.613 | 0.232 | Phosphodiesterase 5A inhibitor | 0.209 0.005 DBMET00493 0.232 0.005 DBMET00499 0.211 0.005 DBMET00498 | DBMET00499 | |
| 0.001 | 0.611 | 0.019 | Egl nine homolog 1 inhibitor | 0.016 0.009 DBMET00493 0.018 0.006 DBMET00499 0.019 0.006 DBMET00498 | DBMET00498 | |
| 0.009 | 0.62 | 0.057 | I kappa B kinase 2 inhibitor | 0.057 0.054 DB11100 | DB11100 | |
| 0.004 | 0.616 | 0.063 | Histamine H1 receptor agonist | 0.063 0.007 DBMET00493 0.053 0.015 DBMET00499 | DBMET00493 | |
| 0.006 | 0.62 | 0.041 | Tryptophan 5 hydroxylase inhibitor | 0.034 0.032 DBMET00499 0.041 0.014 DBMET00498 | DBMET00498 | |
| 0.012 | 0.632 | 0.071 | GABA B receptor agonist | 0.071 0.065 DBMET00493 | DBMET00493 | |
| 0.059 | 0.68 | 0.215 | Tyrosine 3 hydroxylase inhibitor | 0.214 0.112 DBMET00493 0.215 0.11 DBMET00498 0.189 0.157 DB11100 | DBMET00498 | |
| 0.009 | 0.633 | 0.055 | Glutamate (mGluR group III) antagonist | 0.05 0.021 DBMET00493 0.055 0.016 DBMET00499 | DBMET00499 | |
| 0.012 | 0.642 | 0.115 | M18 aspartyl aminopeptidase inhibitor | 0.115 0.075 DBMET00499 | DBMET00499 | |
| 0.008 | 0.641 | 0.08 | GABA A receptor agonist | 0.08 0.063 DBMET00493 | DBMET00493 | |
| 0.065 | 0.698 | 0.405 | MAP kinase kinase 6 inhibitor | 0.405 0.055 DBMET00493 0.31 0.126 DBMET00498 | DBMET00493 | |
| 0.005 | 0.642 | 0.128 | Phosphodiesterase VII inhibitor | 0.064 0.041 DBMET00493 0.128 0.005 DBMET00499 | DBMET00499 | |
| 0.004 | 0.643 | 0.207 | Raf kinase C inhibitor | 0.207 0.009 DBMET00493 | DBMET00493 | |
| 0.005 | 0.644 | 0.06 | Somatostatin 1 antagonist | 0.06 0.015 DB11100 | DB11100 | |
| 0.009 | 0.651 | 0.1 | GABA receptor agonist | 0.1 0.077 DBMET00493 | DBMET00493 | |
| 0.007 | 0.651 | 0.071 | Carbonic anhydrase stimulant | 0.071 0.031 DBMET00493 0.059 0.041 DBMET00499 | DBMET00493 | |
| 0.004 | 0.651 | 0.446 | Raf kinase B inhibitor | 0.446 0.004 DBMET00493 0.371 0.005 DBMET00499 | DBMET00493 | |
| 0.003 | 0.658 | 0.066 | Glutamate (mGluR1) antagonist | 0.066 0.033 DBMET00493 | DBMET00493 | |
| 0.009 | 0.666 | 0.042 | Somatostatin 4 agonist | 0.042 0.02 DBMET00493 | DBMET00493 | |
| 0.004 | 0.662 | 0.549 | Raf kinase inhibitor | 0.549 0.004 DBMET00493 0.383 0.005 DBMET00499 | DBMET00493 | |
| 0.005 | 0.665 | 0.033 | Somatostatin agonist | 0.033 0.021 DB11100 | DB11100 | |
| 0.007 | 0.668 | 0.045 | Dopamine beta hydroxylase inhibitor | 0.045 0.042 DBMET00493 | DBMET00493 | |
| 0.017 | 0.68 | 0.158 | Alpha 2d adrenoreceptor antagonist | 0.086 0.081 DBMET00496 0.158 0.007 DBMET00493 0.142 0.011 DBMET00499 | DBMET00493 | |
| 0.003 | 0.667 | 0.032 | MAP3K8 inhibitor | 0.032 0.014 DBMET00493 | DBMET00493 | |
| 0.004 | 0.675 | 0.075 | Histamine H2 receptor agonist | 0.075 0.009 DBMET00493 0.058 0.016 DBMET00499 | DBMET00493 | |
| 0.009 | 0.681 | 0.088 | Polo-like kinase-1 inhibitor | 0.088 0.065 DBMET00499 | DBMET00499 | |
| 0.019 | 0.696 | 0.112 | CDK3/cyclin E inhibitor | 0.112 0.067 DBMET00493 | DBMET00493 | |
| 0.014 | 0.695 | 0.191 | Focal adhesion kinase 2 inhibitor | 0.191 0.077 DBMET00493 | DBMET00493 | |
| 0.021 | 0.706 | 0.198 | Aurora-C kinase inhibitor | 0.198 0.02 DBMET00493 | DBMET00493 | |
| 0.003 | 0.691 | 0.208 | Somatostatin 2 antagonist | 0.208 0.004 DB11100 | DB11100 | |
| 0.004 | 0.695 | 0.059 | Protein kinase (CK2) beta inhibitor | 0.059 0.005 DBMET00499 0.031 0.028 DBMET00498 0.032 0.026 DB11100 | DBMET00499 | |
| 0.005 | 0.698 | 0.034 | Phosphodiesterase 6A inhibitor | 0.034 0.005 DBMET00493 0.034 0.005 DBMET00499 0.028 0.008 DBMET00498 | DBMET00499 | |
| 0.027 | 0.725 | 0.262 | Superoxide dismutase inhibitor | 0.176 0.147 DBMET00493 0.195 0.123 DBMET00499 0.262 0.067 DB11100 | DB11100 | |
| 0.004 | 0.709 | 0.191 | Phosphodiesterase IV inhibitor | 0.076 0.066 DBMET00493 0.191 0.014 DBMET00499 0.117 0.034 DBMET00498 0.084 0.057 DB11100 | DBMET00499 | |
| 0.016 | 0.721 | 0.123 | Sphingosine 1-phosphate receptor 5 antagonist | 0.123 0.118 DBMET00498 | DBMET00498 | |
| 0.009 | 0.717 | 0.043 | CC chemokine 4 receptor antagonist | 0.043 0.04 DBMET00499 | DBMET00499 | |
| 0.003 | 0.713 | 0.061 | Histamine agonist | 0.061 0.026 DBMET00493 0.05 0.039 DBMET00499 | DBMET00493 | |
| 0.016 | 0.745 | 0.351 | 15-Lipoxygenase inhibitor | 0.351 0.099 DBMET00498 | DBMET00498 | |
| 0.002 | 0.731 | 0.032 | Nicotinic acid receptor 2 antagonist | 0.032 0.011 DBMET00499 | DBMET00499 | |
| 0.009 | 0.739 | 0.062 | Dihydroorotate oxidase inhibitor | 0.062 0.026 DBMET00499 0.061 0.027 DB11100 | DBMET00499 | |
| 0.005 | 0.746 | 0.155 | Aurora-A kinase inhibitor | 0.155 0.038 DBMET00493 | DBMET00493 | |
| 0.003 | 0.746 | 0.058 | Dihydroorotate dehydrogenase inhibitor | 0.058 0.03 DBMET00499 | DBMET00499 | |
| 0.009 | 0.761 | 0.09 | Phosphodiesterase XI inhibitor | 0.09 0.042 DBMET00493 | DBMET00493 | |
| 0.009 | 0.761 | 0.09 | Phosphodiesterase 11A inhibitor | 0.09 0.042 DBMET00493 | DBMET00493 | |
| 0.002 | 0.757 | 0.026 | Acid ceramidase inhibitor | 0.026 0.017 DBMET00499 | DBMET00499 | |
| 0.004 | 0.764 | 0.032 | Alpha 1a adrenoreceptor agonist | 0.032 0.01 DBMET00493 | DBMET00493 | |
| 0.005 | 0.767 | 0.063 | NMDA receptor agonist | 0.063 0.043 DB11100 | DB11100 | |
| 0.004 | 0.767 | 0.031 | DNA polymerase III polC-type inhibitor | 0.015 0.005 DBMET00493 0.031 0.003 DBMET00499 | DBMET00499 | |
| 0.007 | 0.774 | 0.248 | Alpha-glucosidase inhibitor | 0.248 0.188 DBMET00498 | DBMET00498 | |
| 0.019 | 0.793 | 0.458 | MAP kinase 1 inhibitor | 0.25 0.233 DBMET00499 0.458 0.073 DBMET00498 | DBMET00498 | |
| 0.003 | 0.78 | 0.089 | Somatostatin 3 antagonist | 0.089 0.004 DB11100 | DB11100 | |
| 0.02 | 0.797 | 0.324 | Gastrin inhibitor | 0.324 0.019 DB11100 | DB11100 | |
| 0.003 | 0.785 | 0.16 | Histamine H3 receptor agonist | 0.16 0.005 DBMET00493 0.102 0.006 DBMET00499 | DBMET00493 | |
| 0.005 | 0.792 | 0.421 | Prostaglandin dehydrogenase inhibitor | 0.421 0.061 DBMET00498 | DBMET00498 | |
| 0.006 | 0.801 | 0.12 | 5 Hydroxytryptamine 3A agonist | 0.12 0.055 DB11100 | DB11100 | |
| 0.005 | 0.802 | 0.081 | Histamine H2 receptor antagonist | 0.081 0.063 DB11100 | DB11100 | |
| 0.002 | 0.799 | 0.073 | NMDA receptor glycine site agonist | 0.073 0.034 DB11100 | DB11100 | |
| 0.017 | 0.817 | 0.274 | Insulysin inhibitor | 0.274 0.076 DBMET00493 0.205 0.149 DBMET00499 | DBMET00493 | |
| 0.004 | 0.807 | 0.072 | Phosphodiesterase 6B inhibitor | 0.072 0.004 DBMET00493 0.069 0.004 DBMET00499 0.069 0.004 DBMET00498 | DBMET00493 | |
| 0.002 | 0.811 | 0.126 | AMPA receptor antagonist | 0.059 0.025 DBMET00499 0.126 0.008 DBMET00498 | DBMET00498 | |
| 0.012 | 0.83 | 0.06 | Carbonic anhydrase II stimulant | 0.06 0.023 DBMET00493 0.054 0.032 DBMET00499 | DBMET00493 | |
| 0.001 | 0.82 | 0.041 | NMDA receptor subunit 3A antagonist | 0.041 0.024 DBMET00498 | DBMET00498 | |
| 0.002 | 0.823 | 0.062 | NMDA receptor subunit 3B antagonist | 0.062 0.018 DBMET00498 | DBMET00498 | |
| 0.001 | 0.831 | 0.009 | CXC chemokine 3 receptor agonist | 0.009 0.008 DBMET00493 | DBMET00493 | |
| 0.009 | 0.842 | 0.178 | Thyroid hormone beta antagonist | 0.178 0.175 DBMET00498 | DBMET00498 | |
| 0.008 | 0.846 | 0.186 | Thyroid hormone antagonist | 0.186 0.174 DBMET00498 | DBMET00498 | |
| 0.004 | 0.85 | 0.086 | Caspase 7 inhibitor | 0.086 0.049 DBMET00498 | DBMET00498 | |
| 0.005 | 0.859 | 0.188 | Glutamate receptor antagonist | 0.188 0.03 DBMET00498 | DBMET00498 | |
| 0.002 | 0.86 | 0.086 | Calcitonin gene-related peptide antagonist | 0.086 0.003 DBMET00499 0.066 0.005 DBMET00498 0.073 0.004 DB11100 | DBMET00499 | |
| 0.011 | 0.871 | 0.153 | Nav1.3 sodium channel blocker | 0.153 0.046 DBMET00493 0.13 0.064 DBMET00499 | DBMET00493 | |
| 0.009 | 0.879 | 0.074 | Phosphodiesterase 6C inhibitor | 0.061 0.008 DBMET00493 0.064 0.006 DBMET00499 0.074 0.004 DBMET00498 | DBMET00498 | |
| 0.006 | 0.881 | 0.369 | Antiobesity | 0.369 0.078 DB11100 | DB11100 | |
| 0.003 | 0.879 | 0.23 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.23 0.085 DBMET00498 | DBMET00498 | |
| 0.002 | 0.885 | 0.015 | Thyroid hormone alpha agonist | 0.015 0.014 DB11100 | DB11100 | |
| 0.03 | 0.918 | 0.156 | Sphingosine 1-phosphate receptor 2 agonist | 0.156 0.023 DBMET00485 0.156 0.023 DBMET03265 | DBMET03265 | |
| 0.003 | 0.895 | 0.086 | Bromodomain-containing protein 2 inhibitor | 0.086 0.064 DBMET00499 0.08 0.076 DB11100 | DBMET00499 | |
| 0.003 | 0.896 | 0.04 | Phosphodiesterase 6H inhibitor | 0.032 0.006 DBMET00493 0.031 0.007 DBMET00499 0.04 0.004 DBMET00498 | DBMET00498 | |
| 0.003 | 0.896 | 0.04 | Phosphodiesterase 6G inhibitor | 0.032 0.006 DBMET00493 0.031 0.007 DBMET00499 0.04 0.004 DBMET00498 | DBMET00498 | |
| 0.004 | 0.899 | 0.31 | DNA polymerase beta inhibitor | 0.31 0.16 DBMET00498 | DBMET00498 | |
| 0.002 | 0.9 | 0.048 | Somatostatin 5 antagonist | 0.048 0.014 DB11100 | DB11100 | |
| 0.002 | 0.902 | 0.137 | NMDA receptor antagonist | 0.137 0.029 DBMET00498 | DBMET00498 | |
| 0.002 | 0.919 | 0.027 | Kainate receptor 4 antagonist | 0.027 0.016 DBMET00498 | DBMET00498 | |
| 0.003 | 0.929 | 0.035 | Growth factor receptor-bound protein 2 antagonist | 0.035 0.025 DBMET00485 0.035 0.025 DBMET03265 | DBMET03265 | |
| 0.014 | 0.942 | 0.191 | Heme oxygenase stimulant | 0.191 0.002 DBMET00498 | DBMET00498 | |
| 0.004 | 0.941 | 0.056 | Sphingosine 1-phosphate receptor 5 agonist | 0.056 0.032 DBMET00485 0.056 0.032 DBMET03265 | DBMET03265 | |
| 0.005 | 0.948 | 0.31 | Streptokinase A inhibitor | 0.31 0.075 DBMET00498 | DBMET00498 | |
| 0.003 | 0.953 | 0.047 | Bromodomain-containing protein 3 inhibitor | 0.047 0.039 DB11100 | DB11100 | |
| 0.002 | 0.96 | 0.071 | Sphingosine 1-phosphate receptor 3 agonist | 0.071 0.009 DBMET00485 0.071 0.009 DBMET03265 | DBMET03265 | |
| 0.001 | 0.965 | 0.118 | Calcitonin gene-related peptide 1 receptor antagonist | 0.118 0.003 DBMET00499 0.115 0.004 DBMET00498 0.114 0.004 DB11100 | DBMET00499 | |
| 0.004 | 0.973 | 0.113 | M17 leucyl aminopeptidase inhibitor | 0.113 0.084 DBMET00498 | DBMET00498 | |
| 0.002 | 0.979 | 0.08 | Nicotinic acid receptor 2 agonist | 0.08 0.008 DBMET00499 | DBMET00499 | |
| 0.004 | 0.981 | 0.314 | Potassium channel blocker | 0.314 0.042 DB11100 | DB11100 | |
| 0.001 | 0.985 | 0.049 | Cholecystokinin agonist | 0.049 0.007 DB11100 | DB11100 | |
| 0.003 | 0.987 | 0.06 | Mineralocorticoid receptor antagonist | 0.06 0.02 DB11100 | DB11100 | |
| 0.001 | 0.99 | 0.033 | Bradykinin antagonist | 0.033 0.032 DB11100 | DB11100 | |
| 0.002 | 0.992 | 0.054 | Kinesin-like protein 1 inhibitor | 0.054 0.015 DB11100 | DB11100 | |
| 0.002 | 0.992 | 0.054 | Kinesin antagonist | 0.054 0.015 DB11100 | DB11100 | |
| 0.003 | 0.994 | 0.367 | Thioredoxin glutathione reductase inhibitor | 0.367 0.07 DBMET00498 | DBMET00498 | |
| 0.001 | 0.994 | 0.925 | Cholecystokinin A antagonist | 0.925 0.001 DB11100 | DB11100 | |
| 0.001 | 0.995 | 0.946 | Cholecystokinin antagonist | 0.946 0.001 DB11100 | DB11100 | |
| 0.001 | 0.995 | 0.909 | Cholecystokinin B antagonist | 0.909 0.001 DB11100 | DB11100 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |